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1. Abstract 
Cartilage tissue engineering aims to develop a material that can be implanted with cells to repair 
damage in articular cartilage. The extracellular matrix is known to play a key role in regulating stem 
cell behaviour via cell-matrix interactions and integrins are major cell adhesion receptors that act as 
intermediates between cells and their surrounding matrix. Integrin-mediated signalling is known to 
be important in chondrocytes and to drive chondrogenesis. In our study, we investigated integrin 
expression during chondrogenic differentiation of human bone marrow-derived mesenchymal stem 
cells (hMSCs) between three different high density 3D culture methods: pellet culture, micromass 
culture and collagen type II 3D hydrogels. Integrins are αβ heterodimeric transmembrane proteins, 
so we quantified the mRNA expression of every alpha and beta subunit using quantitative 
polymerase chain reaction over a period of 21 days. In all culture methods, alpha and beta integrin 
subunits were down-regulated in hMSCs undergoing chondrogenesis compared to the same cells in 
growth medium, with the exception for integrin subunits α11 and αV which were upregulated in cells 
undergoing chondrogenesis . Moreover, similar transcript expression was identified irrespective of 
the culture system for the alpha subunits related to collagen-binding integrins, while the expression 
of fibronectin- and laminin-binding receptors was greatly variable and dependent on the culture 
method. In conclusion, this work has led to an increased understanding of the expression of integrins 
in hMSCs and during chondrogenesis. This knowledge can be used to design materials that present 
the ligands for these integrins to further improve cartilage tissue engineering 
Key words: cartilage tissue engineering, chondrogenesis, extracellular matrix, integrins, mesenchymal 
stem cells. 
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2. Introduction and Scientific Background 
2.1. Project Aim and Motivation 
Cartilage damages are common in daily life and is a major cause of disability as is osteoarthritis for 
elderly people. Yet cartilage tissue has little self-healing potential due to its avascular nature and the 
limited ability of chondrocytes to migrate and repair the damaged site, making cartilage injury a 
major clinical concern. Specifically, none of the existing treatments are entirely satisfactory, each 
having important drawbacks such as producing fibrocartilage, creating secondary morbid site or 
requiring major surgery. 
Regenerative medicine is a promising alternative treatment that aims to meet clinical need for 
cartilage replacement. Cartilage tissue engineering is a multidisciplinary approach which involves 
combination of cells, scaffolds, and biological cues in order to recreate the tissue. Mesenchymal stem 
cells (MSCs) are a particularly promising cell source, as they can be easily isolated from the patient, 
and are capable of both self-renewal and chondrogenic differentiation. While there have been many 
promising advances in recent years, it remains a challenge to design a material that can promote 
firstly the early adhesion of MSCs, their subsequent chondrogenesis, and then support the fully 
differentiated chondrocytes. 
For this reason, we chose to investigate the changing adhesion requirements of MSCs during 
chondrogenesis, with the intent to better inform the design of cartilage tissue engineering scaffolds. 
It is well established that the surrounding extracellular matrix regulates stem cell behaviour. These 
cell-matrix interactions are mostly mediated by integrins which thus have a central role in 
modulating stem cell differentiation. Integrins are a major surface adhesion receptor family 
composed of 24 distinct heterodimeric members interacting with several ligands found in cartilage  
including collagen types I, II, VI, IX, fibronectin, COMP, osteopontin, laminin, etc. We investigated 
mRNA integrin subunits expression during hMSCs chondrogenic differentiation in three different 
culture systems which are the gold standard pellet culture, micromass culture and collagen type II 
hydrogels. We seek to evaluate whether knowledge of integrin signalling involved in chondrogenesis 
could be used to improve cartilage regenerative medicine, looking at integrin expression during 
hMSCs differentiation in distinct culture model might broaden the understanding of the current 
impediments in cartilage tissue engineering. 
The objective of this project was to understand MSCs adhesion requirements during chondrogenic 
differentiation. Furthermore, the information collected about integrin expression profile can be used 
to design more suitable material that would follow these adhesion requirements as reproducing 
adhesion ligand requirements could contribute to an optimized MSC differentiation in stable 
chondrocytes. 
 
2.2. Native Cartilage Physiology 
Cartilage is found in many places in the body, including the nose, ears, rib cage, and in between the 
bones in joints. Its role is to shape the body, and to protect bone ends by reducing wear in joints. 
Cartilage is a soft connective tissue composed of a highly specialized extracellular matrix and a single 
cell type, chondrocytes. There are three types of cartilaginous tissue which are distinguished by their 
extracellular matrix (ECM) composition, structure and mechanical properties (Table 1). The most 
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common type is hyaline cartilage, found in the larynx, trachea, bronchi, ribs, and on the surface of 
the bone in joints. Hyaline cartilage is mainly composed of collagen type II fibres. In the joint, it lines 
the bone surfaces providing a smooth and lubricating material to protect against joint wear, and 
absorbs the compressive forces exerted in the joint.
3
 Fibrocartilage, another type of cartilage, is 
found in the meniscus and intervertebral discs for instance. It exhibits a high amount of collagen type 
I fibres oriented in order to resist high tensile strength. Compared to hyaline cartilage, it combines an 
important resistance to deformation and a greater resistance to traction forces due to the fibrous 
tissue. Finally, elastic cartilage displays an important flexibility owing to the presence of elastin fibres. 
Its role is to maintain shapes and resist to repetitive flexions. The outer ear, larynx and epiglottis are 
made of elastic cartilage. 
Here, we are focusing on articular hyaline cartilage as the clinical need concerns mainly the 
regeneration of this type of cartilaginous tissue (Section 2.3). Whilst all types of cartilage have limited 
self-healing capacity, articular cartilage injury or degeneration leads to painful conditions and limits 
patients’ movement. Indeed its dynamic and static functions are vital in the achievement of any 
movement: its dynamic role is to provide a friction-less surface between bones in joints in order to 
reduce wear, while its static function is to minimize and distribute stresses on the subchondral bone.
4
 
There is therefore a strong clinical demand to develop durable cartilage repair procedures as 
presently no appropriate solution is available.  
Table 1 - Characteristics of the different cartilaginous tissues  
Cartilage Type Function Characteristic Component 
Hyaline cartilage Reduce wear and resist to deformation Primarily Collagen II 
Fibrocartilage Resist traction and deformation Primarily Collagen I 
Elastic cartilage Highly deformable Presence of Elastin 
 
Chondrocytes are the only cell type present in cartilage. They are highly specialised, fully 
differentiated cells, sparsely distributed, and embedded in the ECM. Chondrocytes are trapped in 
lacunae surrounded by a 2 µm thick pericellular matrix (PCM) displaying a high concentration of 
collagen type VI normally absent in the regular cartilage ECM.
5
 The cartilage cells together with the 
PCM form a structural and functional unit named chondron. Its precise role is not yet known, but is 
thought to play an important role in regulating biomechanical, biophysical, and biochemical 
interactions.
3,6
  
Numerous factors influence chondrocyte physiology including stress,
7
 hydrostatic pressure,
8,9
 
osmotic pressure, dynamic compression,
10,11
 low oxygen tension,
12
 and biochemical factors.
13,14
 In 
vivo studies have demonstrated that mechanical loading significantly stimulates ECM production 
compared to a non-stimulated limb in the same animal. Although the mechanism of transduction is 
not yet well identified it would implicate integrins, but also stretch-activated ion channels. In 
addition to being recepients of signals from their environment, chondrocytes also actively remodel 
the cartilaginous tissue. They produce, maintain and remodel the tissue through anabolic and 
catabolic activities carried out by matrix metalloproteinases (MMPs) and tissue inhibitor of 
metalloproteinases (TIMPs).
15,16
  
Overall, chondrocytes are very sensitive to their microenvironment, and can sense ECM composition 
or mechanical loading changes through several surface receptors, including integrins, and adapt their 
 activity accordingly. Consequently, it is particularly important to take into consideration their
exquisite sensitivity and the need to cater to their environment
chondrocytes.  
Cartilage is, in fact, mainly composed of extracellular matrix (ECM), with the chondrocytes 
representing only up 5% of the volume of the
by the chondrocytes and is comprised of three main components: water, collagen type II fibres 
(except for the fibrocartilage which primarily contains collagen I) and proteoglycans (PGs)
aggrecan is the major PG found in hyaline cartilage. Over 100 ch
sulphate side chains, both glycosaminoglycans (GAGs), are covalently bound to aggrecan.
Furthermore aggrecan also interacts with hyaluronan to from huge proteoglycans aggregates. The 
resulting highly negative charge density endowed by the GAGs side chains together with their 
localisation in the ECM provides cartilage with the osmotic properties required to resist compr
loads (Figure 1).
19
 Indeed, when cartilage deforms as it
expelled to areas under low pressure, leading to an increase of PG concentration in the high pressure 
areas and thus an increase of the osmotic pressure. The PGs repel each other due to their highly 
negative charge, thereby allowing absorption and distribution of mechanical stres
terminates, the high osmotic pressure draws the water back into that region, comparable to the 
behaviour of an elastic sponge.
4
 
 
 
 
 
 
 
 
 
 
 
Figure 1 –Aggrecan (A) and proteoglycan aggregates
are covalently bound to the core protein aggrecan, in turn aggrecan interacts with hyaluronic acid to form proteoglycans 
aggregates. During joint loading, waters is expelled from high pressure region in cartilage increasing PGs aggregates 
concentration hence increasing osmotic pressure. The water flows back  to high osmotic pressure areas when loading 
terminates. Figure inspired by reference 
Articular hyaline cartilage ECM is composed of 68
5-10 wt% of aggrecan. Other components are prese
protein, collagen type I, V, VI, IX and XI, decorin, biglycan, fibromodulin, perl
and COMP.
5,20
  It is an anisotropic and inhomogeneous tissue divided in three highly organised 
macroscopic regions: the superficial zone, the middle zone and the deep zone (
characterised by different structure, organisation and composition. The deep zone contains, for 
instance, more proteoglycans than the two overlying zones. Fibre orientation and chondrocyte 
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 shape, size, gene expression, growth
cartilaginous tissue.
21
 Several studies tried to reproduce native cartilage com
techniques, the outcomes seem promising, indeed 
mechanical properties than single
superficial or deep zone alone.
hypothesise that cell signalling through surface receptors is a major factor influencing chondrogenic 
differentiation and thus our project will focus on the role of surface receptors an
during chondrogenesis rather than attempting to mimic cartilage zonal organisation. 
Figure 2 - Zonal organisation of articular cartilage
structure and composition: the superficial zone, the middle zone and the deep zone. Collagen fib
chondrocyte phenotype depend on the localization in cartilage.
Cartilage does not contain any blood vessels. Chondrocytes are therefore maintained through 
nutrient diffusion rather than active nutrient transport, however the diffusion is helped by 
compression during joint loading. The mobility of the chondrocyt
in lacunae, therefore chondrocytes are not able to migrate to the site of damaged cartilage to repair 
it. Because of its avascular nature, the limited supply of chondrocytes and their poor mobility, hyaline 
cartilage has low inherent capacity for auto
fibrocartilage with lower mechanical properties than hyaline cartilage which leads to impaired 
function. This makes cartilage injury a major clinical issue and an exciti
challenge. Small defects and defects penetrating the subchondral and can repair spontaneously with 
production of hyaline cartilage however for larger defects or for partial thickness defects 
fibrocartilage is produced.
23
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2.3. Cartilage Pathologies and Current Treatments 
The most common degenerative cartilage disease is osteoarthritis (OA). OA is due to a disequilibrium 
of the anabolic and catabolic activities that occur in the articular hyaline cartilage.
24
 The imbalance 
between degradation and synthesis of the cartilage leads to the loss of integrity of the tissue and 
thus to cartilage erosion which result in limited motion, pain or even disability. OA derives from an 
amalgam of numerous factors, including biochemical, biomechanical, inflammatory, and 
immunologic factors.
25
 Over 14% of adults above 25 years are affected by OA however it is mostly 
patients above 45 years old who are affected by this condition (Figure 3).
26
 Although OA is a major 
concern, as indeed,
25
 cartilage damages involves also commonly traumatic sport accident, tear, 
trauma induces injuries, etc, and as aforementioned cartilage has a very low inherent healing 
capacity. Most of the time surgical procedures have to be considered to relieve the patient from pain 
and replace defective cartilage. 
 
Figure 3 - Arthritis Prevalence in USA. One third of the adults between 45-64 years old experiences arthritis, over the age of 
65 it affects  half of the population.
26
 
Currently, the most common treatments for small cartilage injuries are marrow stimulation 
techniques, osteochondral graft, and autologous chondrocytes implantation (ACI). For larger 
cartilage defects, joint replacement is considered. Although outcomes are promising, none of these 
procedures consistently result in clinically patent cartilage. In the marrow stimulation technique, the 
subchondral bone is penetrated at the bottom of the cartilage injury in order to fill the defect with 
blood and to induce bone-marrow derived stem cells to differentiate into chondrocytes in order to 
synthesise cartilage. However these cells are rare and their availability is patient age-dependant. 
Importantly, fibrous tissue is produced rather than hyaline cartilage and due to its inferior 
biomechanical properties a rapid degeneration occurs in the repaired tissue and deterioration of the 
clinical results begins after 18 months.
27,28
 The osteochondral graft is a procedure where a cartilage 
plug with its subchondral bone is transplanted to the damaged site from a non loading bearing site or 
from a cadaver. Although hyaline cartilage is obtained through this method, it involves donor site 
morbidity and is only suitable for small defects.
23
 Another well-known and established treatment is 
autologous chondrocytes implantation, where chondrocytes are extracted from patient’s cartilage, 
expanded in vitro for several weeks and eventually injected into the damaged site. However 
chondrocytes tend to dedifferentiate in vitro which leads to synthesis of fibrous cartilage. Moreover, 
the size of the defect that can be treated with ACI is limited and cannot be applied to large 
defects.
29,30
 Finally, for major injuries, joint replacement is considered but while the outcomes are 
encouraging, the prostheses eventually fail overtime especially in young and active patients. Overall, 
7.60%
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50%
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due to the production of fibrocartilage, risk of infection, donor site morbidity and major surgical 
procedure along with long term rehabilitation, these solutions are far from being optimal. 
Furthermore, the need for treatment for cartilage repair is constantly increasing due to the ageing 
and more active population, along with the growing obesity issue which leads to an increase in 
degenerative joint disease. Indeed over 250,000 knee and hip replacement are performed per year in 
US and this number does not include the small cartilage injuries.
17
 
From this brief review of currently used techniques, it becomes clear that there is a strong clinical 
need for cartilage tissue engineering which would allow treatment of small acute defects but also 
larger defects. 
 
2.4. Cartilage Tissue Engineering Approach and the Use of Mesenchymal 
Stem Cells 
There is a clear need to develop an innovative approach from the state of the art of the current 
treatments available for cartilage injuries. Recently, regenerative medicine has been considered a 
viable option to meet the clinical need for cartilage. Regenerative medicine or tissue engineering is a 
multidisciplinary field that applies engineering principles to life science in order to replace or repair a 
tissue. More specifically, cartilage tissue engineering intends to reproduce hyaline cartilage with 
similar properties, structure and organisation to the native cartilage through an appropriate 
combination of cell type, preferably autologous cells, biomaterials and signalling factors.
17
 Because of 
the low inherent healing capacity of cartilaginous tissue, considerable efforts in the area of cartilage 
tissue engineering and have yielded a number of new materials and cellular approaches. Stem cells, 
and more specifically mesenchymal stem cells (MSCs), are a particularly promising cell candidate for 
cartilage defect repair due to their ability to circumvent the limited supply of autologous 
chondrocytes. MSCs have been shown to successfully undergo chondrogenesis in vitro and Ashton et 
al. were the first to report in vivo chondrogenesis. Important work that followed demonstrated the 
potential of inducing chondrogenesis of MSCs with defined chondrogenic medium containing 
dexamethasone and transforming growth factor-beta (TGF-β).23,31,32 Since then, many different 
protocols have been elaborated to direct MSCs differentiation toward chondrocytes both in vivo and 
in vitro, particularly a combination of TGF-β with bone morphogenetic proteins (BMPs) provided 
excellent results.
33
 
MSCs are suitable candidates for cartilage engineering as they are adult multipotent stem cells with a 
high self-renewal capacity which allows a significant in vitro expansion while retaining their stem cell-
like characteristics. Furthermore, MSCs were shown to differentiate into various cell types under 
appropriate culture conditions including osteocytes, chondrocytes, adipocytes, tenocytes, myocytes, 
neurons, hepatocytes, cardiomycoytes, and astrocytes.
23,34-39
 These cells are rather rare; in bone 
marrow extract it is estimated that only 1 out of 10000 nucleated cells is a MSC. However, they can 
be isolated from numerous tissues among which bone marrow, trabecular bone, skeletal muscle, fat 
tissue, periosteum, and synovium,
40-43
 which makes them easily available. Indeed, the frequency of 
appearance in these tissues is over 100-fold higher than in bone marrow extract.
44
 Although MSCs 
extracted from different tissues show similar behaviour, they have specific properties which are 
related to their tissue origin. Huang et al. studied the chondrogenic potential of progenitor cells 
derived from bone marrow and adipose tissue, and demonstrated that the tissue synthesised by 
13 
 
bone marrow-derived cells was more cartilaginous in comparison to the tissue produced by adipose 
tissue-derived cells as shown by higher accumulation of collagen type II and GAGs.
45
 Another study 
conducted by Sakaguchi et al. compared MSCs derived from five different mesenchymal tissues: 
bone marrow, synovium, periosteum, skeletal muscle, and adipose tissue. Significant differences 
were found among the MSCs when looking at in their proliferation and differentiation abilities, in 
similar conditions synovium-derived cells were superior to other tissue-derived cells in terms of 
multipotentiality.
44
 However for chondrogenesis purposes, bone marrow-derived MSC produced an 
equal amount of ECM than synovium-derived cells, making them an appropriate choice for our study. 
The isolation process of MSCs is challenging as the phenotypic identity is neither unique nor fully 
characterised. These cells share features of multiple cell lineages including endothelial, epithelial, 
hematopoietic, and muscle cells. Yet, no specific surface markers have been identified, thus isolation 
is mostly done through negative selection.
46
 STRO-1 was initially reported as a surface marker for 
bone marrow-derived MSCs,
47
 however other studies showed bone marrow-derived MSCs were 
negative STRO-1,
48
 which illustrates how imprecise and contradictory the information about MSC 
surface markers can render their isolation particularly challenging. Yet, the easy availability of MSCs 
together with their high proliferative potential and multipotency make them appropriate candidates 
for cartilage tissue engineering in order to substitute chondrocytes. Additionally, the use of 
autologous MSC avoids the graft rejection issue. In our study, we used commercially available human 
MSCs. 
 
2.5. Current Limitations of Cartilage Tissue Engineering 
Although some noticeable advances have been made in cartilage tissue engineering, the properties 
and structure of native cartilage have not been completely reproduced. MSCs tend to undergo 
hypertrophy as a terminal differentiation rather than becoming stable chondrocytes. To date, even if 
chondrogenesis from MSCs has been achieved in vitro, many parameters need to be improved in 
order to achieve functioning tissue engineered cartilage beyond simply obtaining chondrocytes. 
For example, R.L. Mauck et al. did a comparative study of the efficiency of matrix formation between 
bovine MSC-derived chondrocytes and healthy mature chondrocytes from the same donor in long-
term agarose culture.
49
 Results showed that the amounts along with the mechanical integrity and 
properties of the matrix produced by MSCs having undergone chondrogenesis were lower than 
mature chondrocytes matrix under the same conditions. This suggests there is an inherent reduction 
in efficiency due to in vitro chondrogenesis which is independent from the biomaterial used. New 
protocols need to circumvent this drawback before using the differentiated cells in a clinical level. 
Undeniably, cartilage tissue engineering is facing some important issues. MSC-derived chondrocytes 
have different phenotypes than native chondrocytes, and despite using numerous growth factors, 
they are hypertrophic and express fibrocartilage markers. In vivo, chondrocytes are known to express 
proteins such as collagen II, SOX9, aggrecan, COMP, decorin and biglycan.
14
 However, in vitro MSC 
chondrogenesis leads to expression of fibrocartilage-features, including collagen I
50
, and hypertrophic 
markers, collagen X, alkaline phosphatase (ALP) and matrix metalloproteinase 13 (MMP13) 
14,51
. 
Ichinose et al. investigated collagen I, II, X and proteoglycan expression in hMSCs entrapped in 
alginate beads with chondrogenic medium for a period of 19 days.
52
 Collagen II, X and proteoglycan 
expression increased the first eight days, but from days 8 through 19, collagen II and proteoglycan 
14 
 
expression dropped while collagen X expression was maintained. They concluded that hMSCs rapidly 
differentiate into chondrocytes which ultimately undergo hypertrophy. Peltari et al. found that in 
pellet culture, both hypertrophic markers collagen X and MMP13 were upregulated before collagen 
II.
51
 All together, it is clear that in vitro chondrogenesis of MSCs it not comparable to developmental 
processes in vivo. 
Until now, MSC-derived chondrocytes obtained through common in vitro chondrogenesis protocols 
showed a different phenotype than mature chondrocytes. They tend to produce ECM proteins 
related to fibrocartilage instead of hyaline cartilage, as shown by high expression of collagen type I, 
and eventually undergo hypertrophy. It seems that  the protocols today available produce a cartilage 
similar to the transient endochondral cartilage rather than a stable hyaline cartilaginous tissue, 
although no mineralization was detected in vitro,
27
 probably because in vitro the TGF-β repress the 
terminal differentiation as it retains the chondrocytes in the pre-hypertrophic state.
53
 Undoubtedly 
MSC chondrogenesis in vitro needs to be optimized to get a matrix with similar properties to its 
native hyaline cartilage counterpart. The great cartilage tissue engineering challenge is to obtain 
stable chondrocytes that do not undergo hypertrophy and produce hyaline cartilage ECM molecules.  
 
2.6. Importance of the Extracellular Matrix 
2.6.1. Influence of the Extracellular Matrix on Cell Behaviour 
The role of the extracellular matrix is not only to provide a mechanical support to the tissue and the 
cells but to regulate fundamental cell function. It has been shown that cell-matrix interactions are 
essential for cell survival and that they modulate cell behaviour. By determining cell shape ECM can 
regulates numerous cellular processes. Interactions with ECM determine the intracellular 
organisation of the cytoskeleton which in turn determines the cell shape thus controls indirectly cell 
growth, proliferation, differentiation, gene expression and secretion but also cell survival. Indeed a 
couple of decades ago, Meredith et al. investigated the role of extracellular matrix as a cell survival 
factor, their study revealed that cells tend to rapidly undergo apoptosis in the absence of any cell-
ECM interactions and that integrins are involved in the process.
54
 Particularly, chondrogenesis is 
highly dependent on cell shape, indeed the round morphology is required to initiate the 
differentiation in vivo.
55
  
To summarise, cell-matrix interactions modulate numerous vital cell processes by regulating 
cytoskeleton organisation and by activating different intracellular signalling pathways. Moreover the 
major surface receptor family mediating these interactions is the integrin family and thus they are of 
great importance in regulating cell behaviour. 
2.6.2. The Integrin Family 
Integrins are cell adhesion receptors involved in both cell-matrix and cell-cell interactions. They are 
αβ heterodimeric transmembrane glycoproteins which relate the extracellular matrix to the 
intracellular machinery. Integrins are not only important for the integrity of the tissue since they are 
physical linkages between the ECM and the cytoskeleton, but importantly, they also trigger 
intracellular signals which regulate cell behaviour and physiology. 
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Table 2 - Vertebrate Integrin Subunits 
                                  List of integrin subunits 
α subunits α1, α2, α3, α4, α5, α6, α7, α8, α9, α10, α11, αD, αE, αL, αM, αV, αW, αX 
β subunits β1, β2, β3, β4, β5, β6, β7, β8 
 
To date, 18 alpha subunits and 8 beta subunits were identified in mammals and these assemble in a 
non-covalent manner to form 24 different integrins with specific ligand properties (Table 2).
56
 The 
heterodimerisation of the two subunits occurs intracellularly thus no free α or β subunits are found 
on the surface of the cell. The specificity of the integrin to a ligand is determined by the α subunit 
which is composed of 7-bladed β-propeller, a thigh, a calf-1, and a calf-2 domain, half of the 18 α 
subunits have an I domain inserted between blade 2 and 3 in the β propeller region which binds the 
ligand. The β subunit is composed of a plexin-sempahorin-integrin domain (PSI), a hybrid domain, a 
βI domain and four epidermal growth factor repeats (EGF) (Figure 4). If the α subunit does not 
contain an I domain, the ligand binding occurs through the βI domain which complex with the 7-
bladded β propeller of the α subunit, moreover the βI domain contains a region binding divalent 
cations involved in the activation of the integrin.
57
 
 
 
 
 
 
 
 
 
 
 
Figure 4 – Representation of an αI domain containing integrin. Only nine out of the 18 different α subunits contains an αI, 
all integrins contain a βI domain in their beta subunit. Figure adapted from reference 56. 
 
 
The integrin family can be classified in different subgroups depending on the ligand they bind or on 
their subunit composition, Figure 5 summarises the complete mammalian set and their major ligands 
specificities, however this figure is highly simplified as it is well known that many integrins are 
promiscuous and bind more than one ligand. In green are depicted the integrins recognizing the RGD 
tripeptide sequence found in fibronectin and vitronectin, in purple are the integrins binding laminin, 
in blue integrins binding collagen are represented, finally in pink are the integrins recognizing Ig-
superfamily receptor and which are thus involved in cell-cell interactions, α4β1 and α9β1 recognise 
both fibronectin and Ig-superfamily receptors.
2
 
 
The extracellular domain of the integrin binds the ligands, usually ECM proteins but may binds with 
soluble cues or other cell surface receptors, and determines the specificity of the integrin. Both α 
and β subunits are involved in ligand recognition, however the alpha subunit plays a central role in 
integrin specificity. The intracellular domain interacts with the cytoskeleton via the beta subunit and 
a variety of intracellular proteins among which include talin, kindlin, and vinculin. The intracellular 
domain is very short, typically less than 50 amino acids, but plays a key functional as it links ECM to 
1 2 3 I domain 4 5 6 7 Thigh Calf-1 Calf-2  
PSI   I domain 1 2 3 4 Thigh  
α 
β 
β propeller domain repeats 
Hybrid domain EGF domains 
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the cytoskeleton through numerous intermediate proteins in order to trigger intracellular signals, all 
known β subunits bind to actin filaments with an exception for α6β4 which binds to intermediate 
filaments.
58,59
  
 
 
It is important to remember that integrins are not only important transmembrane mechanical links 
for cellular adhesion but also involved in activating intracellular signalling pathways. It is well known 
that cell-matrix interactions are required for cell survival as they modulate cell behaviour
54
, their 
binding triggers intracellular pathways which modulate numerous vital cell processes including 
proliferation, shape, motility, polarity, survival, apoptosis, gene expression, matrix remodelling, and 
differentiation.
2,60
 Integrin-ligand binding triggers transduction events very similar to those triggered 
by growth factors. Moreover, integrin signalling pathways involve many different transcription 
factors which influence key genes expression and affect cellular mechanisms. Complex signalling 
launched by integrins involves numerous intracellular proteins modulating cell behaviour. Figure 6 
summarises the main pathways and regulation of cells processes.  
Figure 5 - The Integrin Family. 18 α subunit 
and 8 β subunits assemble to form 24 
distinct heterodimeric integrins with 
different ligand properties. Integrins can be 
classified in subfamilies based on ligand 
specificity (four subgroups are represented) 
or evolutionary relationships. β2 and β7 
expression is mostly restricted to white 
blood cells. α4β1 and α9β1 recognise both 
fibronectin and Ig-superfamily receptors. 
The α subunits containing an αI are 
represented with a star (*). Figure redrawn 
from reference 
2
. 
* 
* * 
* 
* 
* 
* 
* 
* 
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Figure 6 - Integrin Signalling. Integrins influence numerous vital cell processes such as cell shape, migration, survival, 
differentiation, gene expression, etc. The major pathways by which signal transduction occurs are not completely 
elucidated, some of the main pathways are summarised in this figure. Figure adapted from Hynes’ work
2
.  
An important aspect of the integrin family is their bidirectional signalling ability: the outside-in and 
the inside-out signalling.
2
 Extracellular ligand binding to integrins induces conformational changes 
and clustering of the adhesion receptors which in turn generate intracellular signals which regulate 
major cell processes and is named the outside-in signalling (Figure 6 and Figure 8). Conversely, the 
inside-out signalling is the activation of integrin upon information coming from within the cells. 
Indeed it is known that most of the integrins, if not all, are found on the cell surface in an inactive 
state and needs to be activated in order to bind any ligand, through separation of alpha and beta 
cytoplasmic tails. The intracellular regulation of integrin function is known as the inside-out signalling 
(Figure 7). 
 
 
 
 
 
 
 
 
 
 
Figure 7 - Inside-out Signalling. Integrins can be activated 
from within the cells in response to intracellular events, 
this process is known as inside-out signalling and regulates 
integrin affinity for adhesive ligands. Figure inspired by 
reference 
1
. 
Figure 8 - Outside-in Signalling. Integrins are not only 
adhesion receptors, they also transmit information from 
en extracellular environment to the cell by triggering 
signaling pathways upon binding to its ligand. Figure 
inspired by reference 
1
. 
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In conclusion, integrins should be seen both as mechanical linkages between cell and ECM and as 
bidirectional signalling receptors, this dual role makes them essential in regulating cell behaviour and 
are fundamental to numerous vital cellular processes. They are also often referred as 
mechanotransducers as they are involved in the transduction of mechanical stimulus from the ECM 
in biochemical intracellular signals.  
2.6.3. State of the Art of Cell-Matrix Interactions Mediated by Integrins during 
Chondrogenesis 
In this project, we are interested into cell-matrix interactions mediated by integrins and their 
implication in MSC chondrogenic differentiation. As aforementioned, ECM interactions are necessary 
to initiate chondrogenesis. Indeed these interactions are primordial, even more essential than cell-
cell interactions for chondrogenic differentiation. Solursh et al. cultured isolated mesenchyme limb 
cells which had undergone chondrogenesis and expressed chondrocyte phenotype markers under 
appropriate conditions. The differentiation occurred only when cells where cultured in a round 
configuration, it appeared that cell shape and thus indirectly cell-ECM interactions are of major 
importance for chondrogenic differentiation.
61
 In their natural environment, single chondrocytes are 
trapped in lacunae and only have small processes that extent into the matrix but do not interact with 
neighbouring cells.
20
 Undeniably, chondrocytes interact strongly with their direct micro-environment 
and this is why three dimensional (3D) culturing systems are particularly appreciated for in vitro 
chondrogenesis as it mimics more closely in vivo conditions and maintains the round morphology of 
the cells as culture conditions flattening cell morphology are known to encourage chondrocyte 
dedifferentiation. Additionally, it is well established that chondrocytes cultured in monolayer at low 
density rapidly dedifferentiate, conversely it was shown that 3D culture systems stabilize the 
chondrocytic phenotype.
62
 
As aforementioned, cell-ECM interactions modulate fundamental cell functions including 
differentiation. As integrins mediate these interactions they have been extensively studied during 
MSC differentiation. Their role in chondrogenesis was also greatly investigated although it not clear 
yet how they influence the differentiation. Varas et al. studied the expression of α10 and α11 
subunits during hMSC chondrogenesis and discovered that α10 was upregulated while α11 and α1 
were downregulated over time.
63
 They found that cells highly expressing α10 subunit had a high 
chondrogenic differentiation potential, and proposed α10 as a potential marker to predict MSCs 
differentiation state, with α11 being a mesenchymal tissue marker. The expression of fibronectin, 
laminin and their related integrins α3β1, α5β1 and α6β1 during MSC chondrogenic differentiation 
were also investigated by Tavella et al.
64
. Their study showed a clear temporal hierarchy in the 
regulation of fibronectin, laminin and their corresponding integrins. It has been proven that integrins 
have an essential role in the regulation of chondrogenesis. In fact, Hirsch et al. blocked integrin 
signalling using antibodies against α2, α3 or β1 integrin subunits which was shown to suppress 
chondrogenic differentiation and lower chondrocyte survival.
65
 In vivo, β1 tissue-specific knock-out 
causes a severe cartilage phenotype, reduced adhesion to extracellular components, disorganised 
growth plate due to a diminished motility and defective cell division cycle leading to reduced 
proliferation.
66
 Furthermore, in vivo knocking out the α10 subunit led to defects in the growth plate 
along with abnormal chondrocyte morphology and reduced proliferation
67
, while α1 subunit knock-
out led to osteoarthritis.
68
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These results revealed the importance of interactions mediated by integrins between chondrocytes 
and their surrounding extracellular matrix, which also influences integrin expression throughout MSC 
chondrogenesis.  
 
2.7. Investigating Integrin Expression During MSCs Chondrogenesis 
Cartilage tissue engineering research has been mostly focused on mimicking the physical properties 
of native cartilage extracellular environment. Architecture can be reproduced at micrometer and 
nanometer scale, scaffold stiffness and oxygen tension can be matched to native cartilage matrix.  
However, with the exception of decellularised scaffolds, our strategies are poor at mimicking the 
biological properties.  This study aims to provide information that can be used to better match at 
least one aspect of the biological complexity present in the native extracellular matrix. 
In the present work, we investigated the changing adhesion requirements of bone marrow-derived 
MSCs during chondrogenesis by looking at integrin transcript expression over the time course of 
chondrogenesis. Our aim was to identify a temporal transcript expression for each integrin subunit 
during the chondrogenic differentiation.  
As aforementioned, integrins are of major importance throughout chondrogenesis, they modulate 
the differentiation and stabilise the chondrocyte phenotype. Our hypothesis was that integrin 
expression varies during chondrogenesis, as several studies have shown,
63
 which therefore the 
adhesion ligand requirements of MSCs change as they become chondrocytes. Although other studies 
have also focused on integrin expression during chondrogenic differentiation, most of them only 
analysed one or two integrins simultaneously and looked at only one culture system, or looked at 
several integrins but only at the end point of chondrogenesis. In this project, we are interested at 
following the integrin transcript expression in different cell culture methods or scaffolds, and we 
have investigated thus integrin expression profile in three different systems. The objective of this 
project was to understand MSCs adhesion requirements during chondrogenic differentiation and to 
contribute to cartilage tissue engineering by informing the future design of more suitable material 
that would cater to these adhesion requirements. 
2.7.1. Culture Systems and Cell Source 
The first step was the selection the cell type to induce chondrogenic differentiation along with the 
different culture models. As previously mentioned hMSCs are promising candidates for 
chondrogenesis as they can be easily isolated from the patient, and are capable of both self-renewal 
and chondrogenic differentiation. hMSCs are available from numerous tissue and they have specific 
properties which are related to their tissue origin, for chondrogenesis synovium and bone marrow 
derived hMSCs are the most appropriate cells. We opted for bone marrow-derived hMSC as it is the 
best characterised population.
23,44
 
We decided to investigate integrin transcript expression in three distinct 3D high-density cell 
systems. 3D systems are known to encourage chondrogenesis and stabilise chondrocyte phenotype  
by mimicking more closely in vivo conditions and promoting cell-matrix interactions, while 2D 
cultures lead to chondrocytes dedifferentiation.
69
 The 3D systems investigated are: 
 pellet culture, 
20 
 
 micromass culture, and 
 collagen type II gels, 
Pellet culture, prepared by centrifugation is currently the gold standard method for hMSCs 
differentiation into chondrocytes, yet differentiation was shown to be heterogeneous and nutrient 
diffusion in the core of the pellet is hindered by matrix and a very high cell density leading to a 
necrotic core. Hence we decided to look at integrin transcript expression in micromass culture which 
is similar to pellet culture however micromass are formed by high density cell suspension the cell 
density is thus lower than in pellet which allow a better nutrient diffusion to the core of the 
micromass. Moreover micromass culture was shown to be more efficient for hMSC chondrogenesis.
69
 
Finally, the last culture system investigated is collagen type II 3D hydrogels, Bosnakovski et al. 
investigate hMSC chondrogenic differentiation in collagen I, collagen II and alginate gels and showed 
that collagen type II gels showed the best results.
70
 Collagen II, the major component found in native 
hyaline cartilage supports and promotes chondrogenesis of MSCs due to its inherent biological cues 
for chondrocytes. Furthermore, cells are easily harvested in mild conditions from collagen type II 
heat gels from, making it an appropriate material for gene expression profiling as it is known that 
gene expression is rapidly modified under cellular stress.  
2.7.2. Screening Integrin Subunit Expression at Different Time Points 
Integrin transcript expression was evaluated using quantitative real-time polymerase chain reaction 
(qRT-PCR). All known integrins subunits expression was studied by qRT-PCT: 18 α subunits and 8 β 
subunits. Moreover the expression of chondrocyte phenotype markers was assessed: ACAN, SOX9 
and COL1A1, COL2A1 and COL10A1. Other cell lineage markers were studied: PPARG for adipogenesis 
and RUNX2 for osteogenesis. 
MSCs were cultured in either growth medium or chondrogenic medium for a period of 21 days and 
we chose 6 time points over this period to follow the variations in integrin transcript expression, 
hence expression was evaluated on Day 0, 1, 2, 4, 7, 14 and 21.  
 
 
  
21 
 
3. Materials and Methods 
3.1. Routine Cell Culture 
Cryopreserved Passage 1 human mesenchymal stem cells derived from bone marrow were 
purchased from PromoCell (UK). Cells were seeded at 4000 cells/cm
2
 in tissue culture flasks and were 
expanded for two passages in hMSC-optimised growth media obtained from PromoCell, which was 
changed every two days. Approximately 25,000 cells/cm
2
 were typically observed at confluency. Cells 
were frozen at Passage 3 and after thawing, were passaged once before being used in the 
experiments. 
 Freezing cells: Cells were harvested from tissue culture flasks and resuspended in freezing 
medium from Promocell (UK) at 10
6
 cells/ml. 1 ml was transferred to cryovials and stored in a 
freezing container containing isopropyl alcohol at -80°C overnight (freezing rate of 
approximately -1°C/min). Vials were then transferred to the vapour phase of liquid nitrogen 
for long-term storage. 
 Thawing cells: Cryovials were removed from the liquid nitrogen container and submerged 
into a water bath at 37°C for 90 sec. Cells were then transferred to a 50 ml polypropylene 
conical tube, where pre-warmed hMSC growth medium was gradually added. Cells were 
seeded in culture flasks at a density of 4000 cells/cm
2
. 
3.1.1. Pellet Culture 
hMSC pellet culture was carried out following a protocol by Reger et. al. Passage 4 hMSCs were 
trypsinised and aliquots of 2.5 x 10
5
 cells were suspended in 500 µl of hMSC chondrogenic medium or 
hMSC growth medium (Promocell, UK). The pellets were formed by centrifugation at 450 x g for 10 
minutes in 15 ml polypropylene conical tubes. Cells were cultured at 37°C and 5% CO2 with loosened 
caps for gas exchange and medium was changed every three days. Cells were harvested on Day 0, 1, 
2, 4, 7, 14 and 21 for quantitative polymerase chain reaction (qPCR) or histology. 
3.1.2. Micromass Culture 
Micromass culture was performed following the protocol recommended by Promocell [Chondrogenic 
Differentiation and Analysis of MSC, Application note]. Passage 4 hMSCs were harvested and 
resuspended in hMSC growth medium at a concentration of 2.5 x 10
5
 cells per 200 µl in each well of a 
96-well U-bottom suspension culture plate. After 48 hours, spheroids spontaneously formed and 
chondrogenesis was induced using hMSC chondrogenic medium (Promocell, UK). This was designated 
as Day 0. Medium was changed every second or third day. Cells were harvested on Day 0, 1, 2, 4, 7, 
14 and 21 for quantitative polymerase chain reaction (qPCR) or histology. 
3.1.3. 3D Collagen II Gels 
Collagen II heat gels of a final volume 125 µl were prepared in a 96-well plate with 2.5 x 10
5 
Passage 4 
hMSCs suspended within the gel. Acidic bovine articular cartilage-derived collagen II (BD Biosciences, 
UK) was diluted on ice with chondrogenic medium or hMSC growth medium (Promocell, UK) to a 
final concentration of 1.5 mg/ml and 25 µl of HEPES buffer was added per 1 ml. The mixture was 
then neutralised with NaOH to reach a pH of 7.4 and gelation occurred at 37°C. Hydrogels were 
incubated at 37°C and 5% CO2 for 4 to 5 hours then 0.125 µl of hMSC growth or chondrogenic 
medium was added to each well. Medium was changed every second day. Cells were harvested on 
Day 0, 1, 2, 4, 7, 14 and 21 for quantitative polymerase chain reaction (qPCR) or histology. 
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3.2. RNA Extraction 
3.2.1. Pellet culture, Micromass Culture and Collagen II 3D Gels 
Total RNA was isolated from pellets using QIAGEN RNeasy Mini kit (QIAGEN, UK) following the 
manufacturer’s protocol. Pellets, micromass or collagen gels were washed two times in phosphate 
buffered saline (PBS) and 350 µl of RLT lysis buffer (with 1% (v/v) of β-mercaptoethanol) was added. 
The sample was lysed by pipetting or vortexing and stored at -20°C prior RNA extraction. The quality 
and purity of isolated RNA was assessed by spectrophotometry using the Nanodrop 2000c (Thermo 
Scientific, UK). In this technique, the UV absorbance of the samples is measured at critical 
wavelengths: 280 nm for DNA absorbance, 260 nm for RNA absorbance and 230nm for background 
absorbance including salt and proteins. Optical density (OD) is used to quantify RNA and given a 
known extinction coefficient, gives a concentration in ng/µl. The ratio   =
	


	

 
assesses RNA purity and its value should be ideally situated between 1.8 and 2. Another ratio should 
be considered: 

 =
	



	

 , its value should also be situated between 1.8 and 2, a 
lower value indicates contaminants such as proteins or salts. The  

  ratio is critical when 
extracting small amount of RNA, as the value can easily drop under 1. 
3.3. Molecular Biology Tools for Integrin Expression 
3.3.1. cDNA Synthesis 
First-strand cDNA synthesis and quantitative polymerase chain reaction were performed using 
Superscript III Platinium from Invitrogen (UK). Approximately 100 ng total RNA was reverse 
transcribed in a 20 µl reaction volume. The thermocycling programme was 25° for 10 min, 50°C for 
30 min and 85°C for 5 min. Following first-strand synthesis, the sample was treated with RNase. 
3.3.2. Quantitative Polymerase Chain Reaction (PCR) 
Quantitative PCR was performed in a 10 µl final volume with 200 nM of each primer and 2.5 µl 
diluted (1:100 ) cDNA. Thermocycling was carried out for 40 cycles at 95°C for 15 s and 62°C for 30 s 
in a Rotor-Gene 6000 (Corbett Life Science, UK). For amplification of ITGA4 and ITGA6, an 
annealing/elongation temperature of 63°C was required. Each reaction was performed in technical 
triplicates. 
2-steps cycling qPCR 
Hold 50°C for 2 min 
Hold 95°C for 2 min 
40 cycles  95°C, 15s 
 62°C or 63°C, 30s 
Melt curve Temperature raised stepwise 
from 70 to 95°C, 1°C per 5 s 
step. 
  
3.3.3. qPCR Data Analysis: ΔCT and ΔΔCT Methods 
There are two main methods to analyse data obtained from real time qPCR: the absolute 
quantification which determines an input copy number and the relative quantification where the 
change in gene expression is compared to a reference. In this study, the reference was Passage 4 
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hMSCs cultured on tissue culture plastic (i.e. - undifferentiated hMSCs). Datas were analysed with the 
ΔΔCT method for integrin subunit expression and with the ΔCT method for phenotype markers as 
most of the latter were simply not expressed in the undifferentiated hMSC. 
The ΔΔCT method 
As stated in Livak et al.’s paper,
71
 the exponential amplification of the cDNA in PCR is described by 
the following expression: 
 =  ∙ 1 +												 !. 1 
Where An the number of target cDNA copies at the cycle n of the reaction, A0 is the initial number of 
copies, EA the efficiency of the amplification defined during primer validation. At the threshold cycle 
CT  the fluorescence reaches a fixed threshold which is determined by the number of cDNA copies or 
AT: 
# =  ∙ 1 +	$% 											 !. 2 
Similarly for the reference gene (the internal control) that will be use to normalise the PCRs as 
difference in CT might be due to differences in initial cDNA amount, we have: 
' = ' ∙ 1 +													 !. 3 
At the threshold cycle CT : 
'# = ' ∙ 1 +	$% 											 !. 4 
Now we assume that the efficiency of the target and the reference are the same ER=EA=E, dividing AT 
by RT gives: 
#
'# 	= 		
 ∙ 1 +	$%
' ∙ 1 +	$% 	= 	*. ∙ 1 + 
$%, -$%,. = *. ∙ 1 + ∆$% = 0											 !. 5 
Where CT is the difference between the CT of target A and the CT of the reference R: 
	∆2# =	2#, − 2#, 
Where K is a constant, Anorm is equal to A0/R0 the normalized amount of target, and ΔCT the difference 
in threshold cycles between the target and the reference. If we simply rearranged the equation we 
have: 
*. = 0 ∙ 1 + -∆$% 											 !. 6 
Finally, the normalized amount Anorm of a sample X is compared to the normalized amount of a 
sample a calibrator Anorm, cb. :  
*.		5
*.			 	= 	
0 ∙ 1 + -∆$%,6
0 ∙ 1 + -∆$%,78 	= 	 1 + 
-∆∆$% 											 !. 7 
Where ΔΔCT is : 
−∆∆2# =	−:∆2#,5 − 2#,; 
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Finally if the efficiency is close to one, E = 1, the equation simply becomes: 
*.		5
*.			 	= 	 1 + 
-∆∆$% = 2-∆∆$% = <=>?@A	>B	A<CD A											 !. 8 
The final result is thus normalised to a reference, or internal control, and expresses a time fold 
difference in expression between the sample X and the calibrator sample. 
The reference or internal control is usually a housekeeping gene and the calibrator is an untreated 
control. In our study glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was chosen as a 
housekeeping gene and the calibrator sample is Passage 4 hMSCs before trypsinisation from tissue 
culture plastic (TCP). Hence the data are presented as a time fold change relative to the target gene 
expression in the calibrator sample, and the value obtained can vary from 0 to infinity: 
F ≤ HIJI < 1 HIJI = L L	 < M<A< < ∞ 
Less expressed than in hMSCs 
cultured on tissue culture plastic 
(TCP) 
Same expression as in hMSCs 
cultured on TCP 
More expressed than in hMSCs 
cultured on TCP 
 
Assumptions of ΔΔCT methods: 
The ΔΔCT method assumes that the amplification efficiency of the target and reference genes are 
similar and close to 1, however this is an ideal situation. The efficiency is usually not equal due to 
difference in PCR product size, difference in primer annealing efficiency and GC content. The error is 
a function of the PCR efficiency, E, and cycle number, n, and is calculated in % with the following 
equation: 
%	CC>C = 	 P 21 + Q

∙ 100 − 100									 !. 9 
The ΔΔCT method should only be chosen to analyse data if the efficiency between the target gene 
and reference gene are similar, a difference of less than 10% between the two efficiencies is 
considered acceptable.
72
 Obviously small differences of expression will fall in the 10% error and are 
not seen. 
The ΔCT method 
The ΔΔCT method does not apply to genes not expressed in hMSCs cultured on TCP, as the transcript 
expression cannot be expressed relative to the normalising sample. For the phenotypes markers, 
data are expressed as fold-change relative to the housekeeping gene (GAPDH) in the same sample 
using the ΔCT method instead of the ΔΔCT. The data are simply not compared to a calibrator simple 
thus equation 6 from the ΔΔCT above applies: 
*. = 0 ∙ 1 + -∆$% 											 !. 6 
Where:  
	∆2# =	2#,	T	UVV	 − 2#,T		  
Assuming an efficiency of 1: 
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*. = 0 ∙ 2-∆$% 											 !. 10 
The data are expressed as a time fold between 0 and infinity relative to GAPDH expression: 
F ≤ HIJI < 1 HIJI = L L	 < M<A< < ∞ 
Less expressed than GAPDH Same expression than GAPDH More expressed than GAPDH 
 
Assumption with ΔCT methods: 
The ΔCT method assumes an amplification efficiency of 1, however here again the method is 
considered as applicable for efficiency above 0.9. Moreover the error can be calculated using 
equation 9. 
3.4. Primer Pair Validation  
Primers validation is necessary to ensure that the correct cDNA product is amplified, that the 
fluorescence is due to the amplification of the target cDNA and is not due to mispriming or primer-
dimer artifacts. The cycle at which the fluorescence is detected above the background is termed the 
threshold cycle (or CT ) and is used to determined transcript expression. Furthermore, during primer 
validation the primer pair efficiency E is calculated which is particularly important for the comparison 
of gene expression between samples. The threshold at which fluorescence is detected is also 
determined during primer validation. 
3.4.1. Primer Sequences 
Each primer pair was ordered from Invitrogen using sequences obtained from the PrimerBank 
database (Harvard), except primers for ITGA4 and ITGA6 genes which were order through QIAGEN 
(UK). The sequences were as follows:  
Table 3 -  Primer sequences used in quantitative PCR 
Integrin 
Subunits 
or Markers 
Gene 
names 
 
Oligo Name 
 
Oligo Sequence 5’ to 3’ 
Amplicon 
length 
(bp) 
α1 ITGA1 
ITGA1 Fwd v2 CAGCCCCACATTTCAAGTCGT 
174 
ITGA1 Rev v2 ACCTGTGTCTGTTTAGGACCA 
α2 ITGA2 
ITGA2 Fwd v1 GCAACTGGTTACTGGTTGGTT 
167 
ITGA2 Rev v1 GAGGCTCATGTTGGTTTTCATCT 
α3 ITGA3 
ITGA3 Fwd v3 TCAACCTGGATACCCGATTCC 
93 
ITGA3 Rev v3 GCTCTGTCTGCCGATGGAG 
α4 ITGA4 
ITGA4 QIAGEN                 unknown 
70 
                 unknown 
α5 ITGA5 
ITGA5 Fwd v1 GCCTGTGGAGTACAAGTCCTT 
163 
ITGA5 Rev v1 AATTCGGGTGAAGTTATCTGTGG 
α6 ITGA6 
ITGA6 QIAGEN unknown 
142 
                 unknown 
α7 ITGA7 
ITGA7 Fwd v2 TGACCAACATTGATAGCTCAGAC 
212 
ITGA7 Rev v2 GCGCAGGATAACCACAGCA 
α8 ITGA8 
ITGA8 Fwd v1 ATGCCGAGTTCTCTCCTTGC 
110 
ITGA8 Rev v1 TCCCACAATAAGGTCTCCATTCT 
α9 ITGA9 
ITGA9 Fwd v1 AAGGAATTGCCGTTCAGAGGA 
159 
ITGA9 Rev v1 TCATAGGCATCATCTCCGAGG 
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α10 ITGA10 
ITGA10 Fwd v1 CTTCAGTTCTGGGATATGTGCC 
167 
ITGA10 Rev v1 CCAGTCTTCGTAGGAAGGTCT 
α11 ITGA11 
ITGA11 Fwd v2 TCACGGACACCTTCAACATGG 
114 
ITGA11 Rev v2 CCAGCCACTTATTGCCACTGA 
αV ITGAV 
ITGAV Fwd v1 CATCTGTGAGGTCGAAACAGG 
137 
ITGAV Rev v1 TGGAGCATACTCAACAGTCTTTG 
β1 ITGB1 ITGB1 Fwd v2 TTATTGGCCTTGCATTACTGCT 147 
ITGB1 Rev v2 CCACAGTTGTTACGGCACTCT 
β2 ITGB2 ITGB2 Fwd v1 CAACGTATGCGAGTGCCATTC 180 
ITGB2 Rev v1 TTCACGGGGTTGTTCGACAG 
β3 ITGB3 ITGB3 Fwd v1 AGAGCCAGAGTGTCCCAAG 202 
ITGB3 Rev v1 GGCCTCTTTATACAGTGGGTTGT 
β5 ITGB5 ITGB5 Fwd v2 CAGGTGGAGGACTATCCTGTG 190 
ITGB5 Rev v2 GTGCCGTGTAGGAGAAAGGAG 
β6 ITGB6 ITGB6 Fwd v1 CATGTCCGCCAGACTGAGG 101 
ITGB6 Rev v1 GAGCCCAGCTCCTTTATTGTG 
β7 ITGB7 ITGB7 Fwd v1 TGGTTTTGGTTCCTTTGTGGA 119 
ITGB7 Rev v1 GGTGAAAGCTGAATGGTGACT 
β8 ITGB8 ITGB8 Fwd v2 CAGCACTGTGTCAATTCAAAGG 132 
ITGB8 Rev v2 GCAGGCTGTATAACAGGTGGG 
Aggrecan 
 
ACAN 
ACAN Fwd v1 ATTGGTGCCAAAAAGGATCAGT 
101 
ACAN Rev v1 AGGATTGCTTCGAGAAAAACCAG 
Collagen I COL1A1 
COL1A1 Fwd v1 GTCGAGGGCCAAGACGAAG 
143 
COL1A1 Rev v1 CAGATCACGTCATCGCACAAC 
Collagen II COL1A1 
COL2A1 Fwd v1 GGTCTTGGTGGAAACTTTGCT 
114 
COL2A1 Rev v1 GGTCCTTGCATTACTCCCAAC 
Collagen X COL10A1 
COL10A1 Fwd v1 ATGCTGCCACAAATACCCTTT 
134 
COL10A1 Rev v1 GGAATGAAGAACTGTGTCTTGGT 
GAPDH GAPDH 
GAPDH Fwd v1 ATGGGGAAGGTGAAGGTCG 
150 
GAPDH Rev v1 GGGGTCATTGATGGCAACAATA 
PPARγ 
 
PPARG 
PPARG Fwd v1 CCTATTGACCCAGAAAGCGATT 
135 
PPARG Rev v1 CATTACGGAGAGATCCACGGA 
RunX2 
 
RUNX2 
RUNX2 Fwd v1 TCCTATGACCAGTCTTACCCCT 
190 
RUNX2 Rev v1 GGCTCTTCTTACTGAGAGTGGAA 
Sox9 SOX9 
SOX9 Fwd v1 AGCGAACGCACATCAAGAC 
110 
SOX9 Rev v1 GCTGTAGTGTGGGAGGTTGAA 
 
 
3.4.2. Primer Pairs Validation with Quantitative Polymerase Chain Reaction (qPCR) and 
Melt Curve Analysis 
A serial dilution of cDNA from hMSC culture on tissue culture plastic was prepared. In order to get a 
standard curve, five dilutions of cDNA were amplified: 1:10, 1:50, 1:100, 1:1000, and 1:10,000. qPCR 
was performed as described in Section 3.3.2. Each real-time PCR was carried out in technical 
triplicates. For the same primer set, different threshold cycles (CT) were obtained. 
The CT obtained were plotted against dilutions on a logarithmic scale (log10) and once inaccurate 
replicates were removed the standard curve was calculated using Rotor-Gene ScreenClust Software 
(QIAGEN, UK). Technical replicates were considered as inaccurate when CT differences between them 
exceeded half a cycle. 
During primer validation, the primer pair efficiency was calculated, the fit of the standard curve was 
also assessed and most importantly the threshold at with fluorescence is detected was determined. 
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The amplification curves were characterised by four phases: the background, the exponential phase, 
the linear phase and eventually the plateau. The threshold has to be in the exponential phase, and 
should be the lowest possible.
73
 
The efficiency of the pair primers is given by the slope of the standard curve and ideally equals 1 
when slope is -3.32 meaning that the target cDNA is exactly doubled at each PCR cycle: WX>Y = 	 Z[Z\ =
]	$[^
^_` =	−3.32 . Primer pairs were considered validated when their amplification efficiency was 
above 0.9 and the fit of the curve which was expressed by R
2
 above 0.99. 
Moreover the melt curve was verified for each primer pair. As the melting temperature of a cDNA 
double helix depends on its base composition and its length it characterises the cDNA sequence and 
thus only one melting temperature should be identified: the one of the amplified target cDNA. The 
temperature was raised stepwise from 70 to 95°C, starting with 90 s of pre-melt conditioning for the 
first step the temperature was then raised at 1°C at each step, the duration of each step was 5 s. At 
each step the change in fluorescence was measured, the melt curve plots the negative derivative 
with respect to time of the fluorescence against the temperature, the peak of the derivative is 
reached when the cDNA double helix is separated which occurs at the melting temperature. 
3.4.3. Assessing Primers by Gel Electrophoresis 
Analysis of the melt curve ensured a single product was being amplified, but in order to confirm that 
it was the correct amplicon, we performed agarose gel DNA electrophoresis. A 2% gel was 
appropriate for these DNA fragment sizes. Briefly, 2 g of agarose was added to 100 ml 1X TAE buffer 
and dissolved by heating up until reaching boiling temperature. Once cooled down, 10 µl of SYBR 
Safe (Invitrogen, UK) was added. The gel was then poured in the cast and left at room temperature 
until set. 2 µl of 6X loading buffer (Promega, UK) was added to 10 µl of sample and a final volume of 
12 µl was loaded per well. The gel was run for 90 min at 100-120 V and bands were visualised using 
an UV illumination. 
3.5. Histology 
The same procedure for histology was applied to pellet culture, micromass culture and collagen II 
hydrogels. Samples were harversted on day 21, fixed with 3.7 % (w/v) paraformaldehyde in PBS for 
20 min, washed twice in PBS, and stored at 4°C in until being sent for analysis at the histology facility 
of Imperial College London. Hematoxylin and eosin (H&E) staining was performed on the samples to 
evaluate cell morphology, where the hematoxylin stains nuclei in blue while eosin stains mostly the 
cytoplasm in red. Sulphated glycosaminoglycans (GAGs) were visualised with alcian blue staining and 
collagen was detected by picosirius red staining. 
3.6. Statistical Analysis 
The Student t-test was applied in order to determine whether the difference between samples was 
significant, all tests were two-tailored. Two-way ANOVA Analysis of data was also performed on data 
using SigmaPlot version 12. The results were considered significantly different at a P-value of less or 
equal 0.05. 
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4. Results 
4.1. Differentiation Efficiency 
Chondrogenic differentiation was assessed in pellet culture, micromass culture and 3D collagen II 
gels by quantifying the transcript levels of the following chondrocyte phenotypes markers: ACAN, 
SOX9, COL1A1, COL2A1 and COL10A1. We also investigated expression of PPARγ and RUNX2 to 
ensure that the hMSCs were not committed into adipogenic or osteogenic lineage, respectively. 
Additionally, as gene expression alone is not sufficient to assess chondrogenesis, we confirmed 
differentiation with histological staining for GAGs and collagen deposition after 21 days in culture. 
4.1.1. Transcript Levels of Phenotype Markers in Pellet Culture, Micromass Culture 
and Collagen II 3D Hydrogels 
 
Pellet culture: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 - Quantitative analysis of several transcripts in hMSCs cultured in pellet culture up to 21 days in either growth or 
chondrogenic medium. The expression level was normalised such that the level of GAPDH expression was 100%. Bars 
represent the mean ± standard error from three independent experiments performed in technical triplicate. 
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The expression of ACAN remained relatively constant throughout chondrogenesis, while SOX9 
expression almost doubled, however in both cases no significant differences were observed between 
pellet in the growth medium and chondrogenic medium (Figure 9). Bosnakovski et al. have reported 
that in 3D culture systems SOX9 and ACAN expressions were upregulated indifferently to the medium 
(growth or chondrogenic medium).
70
 PPARγ, an adipocyte lineage marker, was not detected at any 
time and RUNX2 expression, a bone lineage marker, was detected from Day 7 onwards, both in 
control and chondrogenic pellets, however its expression level remained very low. Importantly 
collagen type II was detected from Day 7 only in the pellets in chondrogenic medium and reached 
high level of expression, up to 1.4 fold highly than GAPDH. COLA1A1 and COL10A1 were also 
expressed at very high levels from Day 7 onwards, up to 22-times and 15-times GAPDH expression 
respectively. From these data, the hMSCs have undergone chondrogenesis as shown by the 
upregulation of SOX9 and all three Collagen types, however the cells tend to upregulate genes 
associated with fibrocartilage ECM rather than hyaline cartilage as shown by the very high expression 
of COL1A1. Moreover the upregulation of COL10A1 and RUNX2 at late time points suggest that some 
hMSCs might eventually undergo hypertrophy and that few cells might not be fully committed to 
chondrogenic lineage but instead are undergoing osteogenesis. 
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Micromass culture: 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 10 - Quantitative analysis of several transcripts in hMSCs cultured in micromass culture up to 21 days in either 
growth or chondrogenic medium. The expression level was normalised such that the level of GAPDH expression was 100%. 
Bars represent the mean ± standard error from three independent experiments performed in technical triplicate (with the 
exception of Day 21 where N=2). 
  
In micromass cultures, ACAN was significantly upregulated in micromass cultures in growth and 
chondrogenic medium but no significant differences were noticeable between these two culture 
conditions, which could be explain by the 3D environment (Figure 10).
70
 Particularly, the 
upregulation of ACAN is significant between Day 0 and Day 21 of chondrogenic micromasses (p < 
0.05). SOX9 remains constant throughout the differentiation process and no significant differences 
were observed between growth and chondrogenic micromass culture. PPARγ was never detected 
and RUNX2 expression was detected on Day 0 and was slightly upregulated, but this variation was 
not significant, and moreover no differences were observed between control and chondrogenic 
conditions. Concerning the different collagens, collagen type II expression was detectable from Day 7 
onwards only in the cells grown in chondrogenic medium, where its expression level only reached a 
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25% of GAPDH levels. Importantly COL2A1 was not detected in the control cells. COL1A1 expression 
was detected on Day 0 at low levels, a 30-fold increase was detected throughout the chondrogenesis 
for micromass cultured in growth and an 1800-fold increase was detected when cultured in 
chondrogenic medium or 300-time fold GAPDH expression. Similarly for COL10A1 expression a 37-
fold change was measured between Day 0 and Day 21 and a fold increase over 1300 was measured 
between Day 0 and Day 21 for control and chondrogenic micromass cultures respectively.  
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Collagen type II 3D hydrogels: 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ACAN was unexpectedly upregulated in gels cultured in growth medium, while downregulated in 
cells culture in chondrogenic medium, however these variations are not statistically significant 
(Figure 11). Similarly, SOX9 expression remained constant with no significant changes throughout the 
differentiation between gels cultured in chondrogenic medium and control gels. PPARγ was not 
detected and RUNX2 expression was detected throughout the differentiation process in both 
conditions however its variations were not significant. COL2A1 expression was switch on only in cells 
cultured in chondrogenic medium and gradually increased to reach 80% of GAPDH expression level 
on Day 21. COL1A1 expression was detected on Day 0 and was continuously upregulated in 
chondrogenic culture conditions, from Day 7 onwards the expression increase was statistically 
significant, while expression remained constant in control conditions. COL10A1 was detected from 
Day 4 onwards, its expression significantly increased in chondrogenic conditions but remained 
constant in control culture conditions.  
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Figure 11 - Quantitative analysis of several transcripts in hMSCs cultured in pellet culture up to 21 days in either growth or 
chondrogenic medium. The expression level was normalised such that the level of GAPDH expression was 100%. Bars 
represent the mean ± standard error from three independent experiments performed in technical triplicate. (Few time 
points N=2). 
 4.1.2. Histology in Pellet
 
Pellet culture: 
 
  
 
 
 
 
 
 
 
Figure 12 – Histology in pellet culture. Cells cultured in pellet were fixed 
(A, D), for cytoplasm and nucleus staining, 
proteoglycans deposition. Scale bar 50 µ
Pellets grown in chondrogenic medium were 
blue compared to pellets grown in control medium, showing an important
GAGs and collagen as expected after chondrogenesis
 
Micromass culture: 
 
 
 
 
 
 
 
 
 
Figure 13 - Histology in micromass culture. Cells cultured in pellet were fixed on Day 21 and sta
eosin (A, D), for cytoplasm and nucleus staining, s
proteoglycans deposition. Scale bar 50 µ
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 Culture, Micromass Culture and 3D Collagen II 
 
on Day 21 and stained with hematoxylin and eosin 
sirius red (B, E) to detect collagen deposition and alcian blue (
m. 
strongly stained with both staining 
 accumulation of both 
 (Figure 12). 
ined with hematoxylin and 
irius red (B, E) to detect collagen deposition and a
m. 
Sirius red Alcian blue
B C 
E F 
Sirius red Alcian blue
B C 
E F 
Hydrogels 
 
C, F) for 
sirius red and alcian 
lcian blue (C, F) for 
 
 
 Accumulation of collagens was shown in micromass cultures by u
in chondrogenic medium were positively stained yet weakly, however no staining was observed in 
the control micromass culture 
conditions and absent in control 
 
Collagen type II gels: 
 
 
 
 
 
 
 
 
 
Figure 14 - Histology in collagen type II gels
eosin (A, D), for cytoplasm and nucleus staining, 
proteoglycans deposition. Scale bar 50 µ
The gels cultured in growth and chondrogenic medium were both strongly stained for collagen with 
Sirius red as the gels are made of collag
conditions and a strong staining is consequently normal
control conditions the staining was clearly negative while in chondrogenic medium we had a weak 
alcian blue staining confirming PGs deposition.
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sing Sirius red, micromass cultured 
(Figure 13). The alcian blue staining was weak in chondrogenic 
conditions. 
. Cells cultured in pellet were fixed on Day 21 and stained with hematoxylin and 
sirius red (B, E) to detect collagen deposition 
m. 
en, no differences were expected between these two 
 (Figure 14). Concerning PGs staining, in 
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4.2. Integrin expression 
The expression of each integrin subunit listed in Table 2 were analysed at least once throughout the 
21-day experiment for the three different culture methods which are pellet culture, micromass 
culture and collagen type II 3D gels. The integrin subunits having a low and particularly irregular 
expression pattern and subunits that were not expressed were dropped at this point of the 
experiment. We carried on with the following subunits (Table 4): 
Table 4 - Integrin subunits investigated in the present study 
 Alpha subunits Beta subunits 
Subunits studied 
throughout the 21 days-
experiment 
ITGA1, ITGA2, ITGA3, ITGA5, 
ITGA6, ITGA6, ITGA7, ITGA10, 
ITGA11 and ITGAV 
ITGB1, ITGB3, ITGB5 and 
ITGB8 
 
Subunits discarded 
ITGB8, ITGB9, ITGAD, ITGAE, 
ITGAL, ITGAM, ITGAW and 
ITGAX 
ITGB2, ITGB4, ITGB6 and 
ITGB7 
 
The investigated integrin subunits expression levels are relative to the expression in untreated 
hMSCs cultured on tissue culture plastic, a colour legend according to the fold-change was assigned 
to the integrin transcript expression levels. The data are summarised in the following tables as the 
mean value ± standard error (Table 5, 6, and 7).  
 
Legend: fold change compare to untreated hMSC cultured on tissue culture plastic. 
 
       
 
 
  
  -10   - 5              - 2           0         +2          +5        +10 
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4.2.1. Pellet Culture 
 
Table 5 - Integrin transcript expression in pellet culture in either growth medium (A) or chondrogenic medium (B). The 
expression level was quantified by qPCR. Data are shown as mean ± standard error from three independent experiments 
performed in technical triplicate. 
Pellet Cultures – Growth medium 
Day 0 Day 1 Day 2 Day 4 Day 7 Day 14 Day 21 
ITGA1 1.85 ± 0.32 1.33 ± 0.28 1.48 ± 0.33 4.56 ± 1.41 6.94 ± 2.40 18.93 ± 4.81 11.46 ± 3.28 
ITGA2 2.06 ± 0.93 1.97 ± 0.44 2.41 ± 1.05 4.80 ± 0.83 4.69 ± 0.96 3.30 ± 1.03 2.28 ± 0.63 
ITGA3 2.55 ± 0.41 -1.52 ± 0.35 -1.74 ± 0.20 1.15 ± 0.09 1.56 ± 0.30 2.28 ± 0.56 2.29 ± 0.59 
ITGA4 1.40 ± 0.27 -2.92 ± 0.49 -2.74 ± 1.45 -1.67 ± 0.47 -1.34 ± 0.47 1.36 ± 0.37 -1.36 ± 0.35 
ITGA5 1.11 ± 0.32 1.04 ± 0.15 -1.15 ± 0.07 -1.06 ± 0.29 -1.16 ± 0.23 -1.55 ± 0.30 -1.50 ± 0.30 
ITGA6 1.82 ± 0.32 -3.91 ± 1.19 -4.27 ± 0.89 -1.58 ± 0.26 -1.76 ± 0.57 -2.37 ± 0.14 -2.43 ± 1.12 
ITGA7 6.75 ± 1.79 1.34 ± 0.35 -1.08 ± 0.09 2.35 ± 0.46 3.77 ± 1.51 11.94 ± 4.16 4.74 ± 1.91 
ITGA10 7.42 ± 1.81 2.01 ± 0.87 1.49 ± 0.40 4.62 ± 0.57 24.76 ± 8.72 30.57 ± 9.31 21.97 ± 6.08 
ITGA11 2.37 ± 0.28 -1.23 ± 0.19 -1.66 ± 0.25 1.72 ± 0.28 5.62 ± 2.18 8.76 ± 2.16 10.36 ± 2.61 
ITGAV 1.87 ± 0.55 -1.93 ± 0.54 -1.86 ± 0.25 -1.16 ± 0.20 2.14 ± 0.54 1.95 ± 0.35 1.83 ± 0.59 
ITGB1 1.72 ± 0.48 -2.35 ± 0.48 -2.38 ± 0.70 -1.38 ± 0.38 1.39 ± 0.34 1.77 ± 0.35 1.73 ± 0.40 
ITGB3 1.78 ± 0.46 1.09 ± 0.30 1.86 ± 0.52 2.30 ± 0.82 1.03 ± 0.31 1.24 ± 0.13 1.53 ± 0.36 
ITGB5 1.09 ± 0.15 -2.33 ± 0.44 -2.09 ± 0.41 1.30 ± 0.17 4.23 ± 1.12 5.70 ± 1.31 4.26 ± 1.06 
ITGB8 3.52 ± 0.83 2.21 ± 0.53 6.94 ± 1.78 11.81 ± 3.35 31.15 ± 7.89 38.65 ± 6.76 27.71 ± 11.56 
 
Pellet cultures – Chondrogenic medium 
Day 0 Day 1 Day 2 Day 4 Day 7 Day 14 Day 21 
ITGA1 1.85 ± 0.32 1.38 ± 0.12 1.63 ± 0.57 2.07 ± 0.43 4.08 ± 1.25 4.82 ± 1.90 2.74 ± 0.98 
ITGA2 2.06 ± 0.93 -2.84 ± 0.38 -3.40 ± 0.07 -2.84 ± 0.39 -2.35 ± 0.47 -6.23 ± 2.19 -16.07 
ITGA3 2.55 ± 0.41 -1.30 ± 0.72 -5.78 ± 1.09 -6.74 ± 1.04 -3.60 ± 1.30 -16.20 ± 7.59 -15.91 ± 4.23 
ITGA4 1.40 ± 0.27 -8.58 ± 1.93 -10.47 ± 0.52 -4.58 ± 1.11 -2.63 ± 0.57 -2.48  ± 1.13 -5.85 ± 1.73 
ITGA5 1.11 ± 0.32 1.30 ± 0.12 -1.42 ± 0.22 -1.78 ± 0.2 -2.19 ± 0.39 -4.79 ± 0.89 -5.80 ± 1.10 
ITGA6 1.82 ± 0.32 -12.79 ± 0.80 -20.31 ± 8.31 -7.89 ± 3.62 -5.21 ± 1.49 -9.53 ± 4.95 -10.07 ± 4.51 
ITGA7 6.75 ± 1.79 -1.00 ± 0.31 -1.57 ± 0.16 2.19 ± 0.73 3.35  ± 0.24 9.01  ± 3.98 2.11  ± 0.3 
ITGA10 7.42 ± 1.81 2.80 ± 0.20 1.88 ± 0.52 3.81 ± 1.20 8.60 ± 1.96 6.15 ± 2.39 6.43  ± 2.01 
ITGA11 2.37 ± 0.28 2.03 ± 0.97 1.71 ± 0.90 2.37 ± 0.79 6.43 ± 1.45 13.50 ± 3.98 14.46 ± 1.56 
ITGAV 1.87 ± 0.55 -1.46 ± 0.62 -1.11 ± 0.30 3.13 ± 0.55 4.81 ± 1.23 3.23 ± 0.81 2.74 ± 0.68 
ITGB1 1.72 ± 0.48 -2.40 ± 0.60 -2.59 ± 0.60 -2.00 ± 0.53 -1.04 ± 0.26 1.13 ± 0.34 1.08 ± 0.32 
ITGB3 1.78 ± 0.46 -1.65 ± 0.38 -2.40 ± 0.88 -2.26 ± 0.59 -1.44 ± 0.59 -17.40 -7.98 ± 2.86 
ITGB5 1.09 ± 0.15 -3.17 ± 1.03 -3.89 ± 1.16 -2.60 ± 0.65 -1.23 ± 0.29 -1.06 ± 0.30 1.45 ± 0.30 
ITGB8 3.52 ± 0.83 -1.24 ± 0.46 1.59 ± 0.84 3.74 ± 1.11 4.53 ± 0.89 2.01 ± 0.61 2.44 ± 1.23 
A 
B 
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4.2.2. Micromass Culture 
 
Table 6 - Integrin transcript expression in micromass culture in either growth medium (A) or chondrogenic medium (B). The 
expression level was quantified by qPCR. Datas are shown as mean ± standard error from three independent experiments 
performed in technical 
Micromass Cultures – Growth medium 
Day 0 Day 1 Day 2 Day 4 Day 7 Day 14 Day 21 
ITGA1 1.25 ± 0.35 3.88 ± 0.67 5.96 ± 1.85 17.07 ± 5.69 18.88 ± 3.91 20.36 ± 9.83 18.55 ± 11.41 
ITGA2 1.39 ± 0.45 3.15 ± 1.04 2.63 ± 1.03 3.82 ± 1.30 3.57 ± 1.13 2.12 ± 0.83 1.22 ± 0.68 
ITGA3 -5.55 ± 1.92 -2.28 ± 0.84 -2.05 ± 0.86 1.02 ± 0.41 1.14 ± 0.41 -1.25 ± 0.30 1.52 ± 0.87 
ITGA4 -4.07 ± 0.82 -2.31 ± 0.24 -2.82 ± 0.44 -1.28 ± 0.14 -1.29 ± 0.63 -1.30 ± 0.77 -1.68 ± 1.20 
ITGA5 -1.70 ± 0.24 -1.55 ± 0.27 -1.62 ± 0.30 -1.86 ± 0.34 -2.29 ± 0.67 -3.32 ± 0.59 2.65 ± 1.44 
ITGA6 -15.01 ± 5.19 -9.18 ± 4.12 -8.47 ± 3.59 -4.53 ± 2.05 -3.97 ± 0.85 -3.33 ± 2.13 -3.60 ± 2.30 
ITGA7 -1.34 ± 5.19 3.22 ± 1.44 2.89 ± 1.87 8.97 ± 6.15 3.81 ± 1.31 3.09 ± 1.84 3.49 ± 2.20 
ITGA10 1.27 ± 0.54 3.43 ± 1.26 7.74 ± 4.86 25.25 ± 16.05 20.38 ± 8.68 18.72 ± 7.34 16.02 ± 9.04 
ITGA11 -2.41 ± 0.70 -1.10 ± 0.15 1.12 ± 0.45 3.00 ± 0.60 5.76 ± 2.31 4.71 ± 1.86 6.36 ± 3.10 
ITGAV -4.23 ± 0.67 -1.44 ± 0.18 -1.06 ± 0.34 2.07 ± 0.52 2.10 ± 0.36 2.45 ± 0.52 1.83 ± 0.81 
ITGB1 -3.94 ± 1.04 -1.74 ± 0.47 -1.91 ± 0.55 -1.04 ± 0.23 2.19 ± 0.83 3.18 ± 1.36 2.87 ± 1.25 
ITGB3 -1.20 ± 0.19 1.59 ± 0.27 1.49 ± 0.14 1.47 ± 0.31 -1.21 ± 0.20 1.28 ± 0.12 1.25 ± 0.67 
ITGB5 -1.54 ± 0.36 1.81 ± 0.24 2.24 ± 0.59 4.66 ± 1.11 5.52 ± 1.50 5.68 ± 1.36 6.23 ± 2.63 
ITGB8 3.93 ± 0.27 6.98 ± 0.72 15.13 ± 1.75 20.36 ± 5.16 24.35 ± 6.80 34.26 ± 12.36 52.47 ± 23.69 
 
Micromass cultures – Chondrogenic medium 
Day 0 Day 1 Day 2 Day 4 Day 7 Day 14 Day 21 
ITGA1 1.25 ± 0.35 3.61 ± 1.39 5.16 ± 1.68 5.93 ± 2.45 4.83 ± 1.69 5.07 ± 2.49 5.16 ± 2.54 
ITGA2 1.39 ± 0.45 2.81 ± 1.12 2.78 ± 0.92 1.96 ± 0.83 -1.83 ± 0.81 -3.31 ± 0.90 -16.89 
ITGA3 -5.55 ± 1.92 -3.25 ± 1.04 -1.98 ± 0.75 -1.88 ± 0.63 -4.52 ± 0.82 -6.48 ± 1.09 -4.52 ± 3.06 
ITGA4 -4.07 ± 0.82 -2.54 ± 1.19 -3.40 ± 1.35 -1.49 ± 0.73 -2.87 ± 0.78 -2.71 ± 0.99 -4.96 
ITGA5 -1.70 ± 0.24 2.01 ± 0.34 2.32 ± 0.61 1.80 ± 0.57 -1.92 ± 0.65 -4.71 ± 0.38 -2.20 ± 1.27 
ITGA6 -15.01 ± 5.19 -6.34 ± 1.94 -5.56 ± 2.17 -4.42 ± 2.97 -4.55 ± 2.68 -5.54 ± 4.06 -8.47 ± 6.28 
ITGA7 -1.34 ± 5.19 8.41 ± 3.63 10.57 ± 6.96 13.82 ± 9.97 4.21 ± 1.82 3.39 ± 1.92 2.52 ± 1.78 
ITGA10 1.27 ± 0.54 5.50 ± 2.39 11.75 ± 5.79 19.70 ± 10.88 12.24 ± 3.09 3.74 ± 0.21 6.97 ±  3.83 
ITGA11 -2.41 ± 0.70 -1.11 ± 0.52 2.38 ± 0.91 7.48 ± 1.36 8.29 ± 2.56 7.93 ± 1.68 15.43 ± 8.35 
ITGAV -4.23 ± 0.67 2.99 ± 0.12 4.50 ± 0.98 7.12 ± 2.15 4.75 ± 1.06 3.20 ± 0.37 4.12 ± 1.90 
ITGB1 -3.94 ± 1.04 -1.16 ± 0.39 1.38 ± 0.36 1.98 ± 0.34 3.19 ± 1.52 3.33 ± 1.67 4.89 ± 2.40 
ITGB3 -1.20 ± 0.19 1.21 ± 0.32 1.85 ± 0.88 -1.07 ± 0.61 -2.92 ± 1.36 -5.98 3.92 
ITGB5 -1.54 ± 0.36 1.59 ± 0.29 2.07 ± 0.42 3.01 ± 0.52 2.16 ± 0.23 1.79 ± 0.32 3.40 ± 1.43 
ITGB8 3.93 ± 0.27 5.72 ± 1.44 10.58 ± 3.36 10.12 ± 4.58 9.54 ± 1.37 12.02 ± 2.59 12.05 ± 7.25 
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4.2.3. Collagen II 3D Gels 
 
Table 7 - Integrin transcript expression in collagen type II gels in either growth medium (A) or chondrogenic medium (B).  
The expression level was quantified by qPCR. Datas are shown as mean ± standard error from three independent 
experiments performed in technical. (For some time points N=1 or 0, orange cases). 
Collagen type II 3D gels – Growth medium 
Day 0 Day 1 Day 2 Day 4 Day 7 Day 14 Day 21 
ITGA1 1.04 ± 0.08 -1.43 ± 0.21 -1.30 ± 0.28 4.94 ± 1.77 13.07 ± 1.30 12.26 ± 3.81 14.42 ± 4.22 
ITGA2 -1.76 ± 0.48 1.07 ± 0.09 1.36 ± 0.03 1.28 ± 0.13 4.85 ± 1.46 4.53 ± 1.56 3.07 ± 0.98 
ITGA3 -2.06 ± 0.99 -8.40 ± 2.29 -9.72 ± 1.84 -5.81 ± 2.59 -1.63 ± 0.32 -1.34 ± 0.19 -1.17  ± 0.21 
ITGA4 1.85 ± 0.05 -5.60 ± 0.67 -5.39 ± 1.47 -2.52 ± 0.06 1.54 ± 0.08 1.60 ± 0.21 1.22 ± 0.14 
ITGA5 -1.73 ± 0.18 -1.88 ± 0.17 -3.02 ± 0.18 -2.63 ± 0.12 -2.17 ± 0.66 -2.21 ± 0.68 -3.86 ± 0.64 
ITGA6 -1.04 ± 0.45 -8.86 ± 3.00 -15.81 ± 5.30 -6.56 ± 3.07 -1.90 ± 0.85 -2.16 ± 0.83 -3.85 ± 1.47 
ITGA7 -1.27 ± 0.25 -3.32 ± 1.52 -4.85 -1.80 ± 0.76 -1.49 ± 0.27 -2.33 ± 0.99 -2.18 ± 0.80 
ITGA10 2.09 ± 0.09 -2.48 ± 0.34 -2.65 ± 0.26 1.52 ± 0.15 9.52 ± 0.66 11.45 ± 2.48 9.59 ± 3.09 
ITGA11 -2.15 ± 0.91 -4.42 ± 0.58 -5.28 ± 2.25 -1.93 ± 0.75 2.17 ± 0.37 2.33 ± 0.36 4.09 ± 1.67 
ITGAV 1.17 ± 0.51 -2.94 ± 1.15 -4.87 ± 2.27 -3.61 ± 1.49 1.19 ± 0.39 -1.24 ± 0.27 1.18 ± 0.26 
ITGB1 1.17 ± 0.10 -3.03 ± 0.14 -4.77 ± 0.18 -2.96 ± 0.07 1.23 ± 0.07 1.28 ± 0.25 1.14 ± 0.16 
ITGB3 1.01 ± 0.07 -1.04 ± 0.44 -1.04 ± 0.17 1.22 ± 0.25 -1.13 ± 0.19 1.22 ± 0.30 1.49 ± 0.47 
ITGB5 1.94 ± 1.08 -2.48 ± 0.58 -3.10 ± 0.41 -1.43 ± 0.20 3.26 ± 0.57 2.88 ± 0.66 3.48 ± 0.93 
ITGB8 13.45 ± 11.09 -1.49 ± 0.21 1.64 ± 0.43 7.51 ± 0.26 23.89 ± 8.48 21.76 ± 5.44 23.65 ± 6.06 
 
Collagen type II gels – Chondrogenic medium 
Day 0 Day 1 Day 2 Day 4 Day 7 Day 14 Day 21 
ITGA1 1.04 ± 0.08 -1.23 ± 0.10 1.78 ± 0.79 2.75 ± 0.75 3.19 ± 0.66 1.35 ± 0.24 1.06 ± 0.16 
ITGA2 -1.76 ± 0.48 -3.01 ± 1.01 -2.32 ± 0.96 -1.68 ± 0.72 -3.07 ± 1.00 -14.33 ± 6.78 -36.17 
ITGA3 -2.06 ± 0.99 -14.11 ± 5.41 -14.17 ± 4.54 -5.60 ± 1.15 -8.70 ± 3.34 -10.36 -8.91 ± 4.13 
ITGA4 1.85 ± 0.05 -7.78 ± 1.16 -7.73 ± 1.45 -2.29 ± 0.92 -1.51 ± 0.24 -4.04 ± 1.65 -2.70 ± 0.59 
ITGA5 -1.73 ± 0.18 -1.12 ± 0.17 -1.29 ± 0.26 -1.80 ± 0.48 -4.0 ± 0.58 -11.03 ± 1-41 -10.74 ± 1.49 
ITGA6 -1.04 ± 0.45 -12.39 ± 3.43 -13.55 ± 5.57 -11.39 ± 8.28 -8.65 ± 2.54 TBD TBD 
ITGA7 -1.27 ± 0.25 -3.88 ± 1.66 -1.80 ± 0.11 1.42 ± 0.34 -1.38 ± 0.46 TBD -7.24 
ITGA10 2.09 ± 0.09 1.06 ± 0.28 1.37 ± 0.45 3.43 ± 1.59 2.65 ± 0.24 1.31 ± 0.16 2.38 ± 0.23 
ITGA11 -2.15 ± 0.91 -2.07 ± 0.64 -1.32 ± 0.19 3.30 ± 1.01 3.04 ± 0.34 3.76 ± 0.76 4.51 ± 0.99 
ITGAV 1.17 ± 0.51 1.35 ± 0.44 2.24 ± 0.17 2.47 ± 0.45 2.06 ± 0.20 1.27 ± 0.37 1.29 ± 0.49 
ITGB1 1.17 ± 0.10 -2.76 ± 0.44 -1.97 ± 0.51 -1.24 ± 0.47 1.06 ± 0.15 -1.79 ± 0.07 -1.80 ± 0.16 
ITGB3 1.01 ± 0.07 -2.56 ± 1.16 2.99 ± 1.37 -2.44 -2.32 -7.58 TBD 
ITGB5 1.94 ± 1.08 -3.13 ± 0.83 -2.60 ± 0.83 -1.62 ± 0.65 -1.29 ± 0.22 -1.68 ± 0.18 -1.45 ± 0.15 
ITGB8 13.45 ± 11.09 -1.42 ± 0.56 1.66 ± 0.62 4.46 ± 1.82 6.64 ± 1.69 8.22 ± 2.84 14.78  9.75 
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4.2.4. Expression of Alpha Integrin Subunits in the Different Culture Systems 
ITGA1: 
In the three culture methods, the ITGA1 expression remained constant in cells cultured in 
chondrogenic medium, while it was increased more than tenfold throughout the 21 days in growth 
medium (Figure 15). Moreover at the earliest time points, both control and chondrogenic conditions 
behave similarly in the three models. The expression pattern was significantly different over time 
between the growth and chondrogenic conditions in pellet culture and in collagen gels, but not in 
micromass due to high variability of ITGA1 expression in samples within the same group in 
expression levels. Finally, from Day 4 until the end of the experiment the expression of ITGA1 was 
always found in higher amount in cells cultured in growth medium than hMSCs undergoing 
chondrogenesis.  
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Figure 15 - ITGA1 expression over time in pellet 
culture (A), micromass culture (B) and collagen type II 
gels (C). Expression of ITGA1 is relative to untreated 
hMSCs expression cultured on tissue culture plastic. A 
similar trend is observed in the three methods: 
starting with similar level of expression an important 
upregulation is observed in control conditions while 
expression remains stable in chondrogenic 
conditions. ITGA1 expression pattern was significantly 
different between growth and chondrogenic 
conditions. (N=3 independent experiments, mean ±
standard error). 
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ITGA2: 
Here again the same trend is observed in the three different culture methods. Indeed, starting with 
similar initial levels of ITGA2 expression in growth and chondrogenic conditions, the expression of 
ITGA2 was importantly downregulated in the latter after Day 7 in each culture methods while 
remained relatively constant in the control samples (Figure 16). The differences in expression level 
between growth and chondrogenic conditions were significant in pellet culture and in collagen type II 
gels but not in micromass culture. Overall the expression of ITGA2 was higher in cells cultured in 
growth medium than in cells undergoing chondrogenic differentiation. 
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Figure 16 - ITGA2 expression over time in pellet 
culture (A), micromass culture (B) and collagen type II 
gels (C). Expression of ITGA1 is shown relative to 
untreated P4 hMSCs expression cultured on tissue 
culture plastic. The same trend is identified in the 
three culture methods, moreover the expression 
differences between control and chondrogenic 
conditions were significant in pellet culture and 
collagen type II gels. The expression of ITGA2 was 
higher in control conditions than in chondrogenic 
conditions. (N=3 independent experiments, mean ±
standard error). 
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ITGA3: 
The variation of ITGA3 expression showed analogous behaviour in all three culture methods (Figure 
17). At early stages of chondrogenesis, ITGA3 expression is almost identical in control and 
chondrogenic groups, but at later time points the expression in hMSCs grown in chondrogenic 
medium tends to decrease, while expression in control cells remains at constant level, an expression 
similar to untreated hMSCs. The expression differences between growth and chondrogenic 
conditions were significant from Day 2 onwards in pellet culture, while for collagen II 3D hydrogels 
significance was reached from Day 7 onwards and in micromass culture only Day 14 showed 
significant difference between the two conditions. Moreover the expression profile was significantly 
different over time between the growth and chondrogenic conditions in pellet culture and in collagen 
gels. Most interestingly, on Day 21 the ITGA3 expression in growth condition in each method reached 
the same expression in hMSC cultured on TCP in collagen type II gels. The expression was importantly 
downregulated at the first stage but was upregulated from Day 2 onwards to reach a plateau around 
-1. In micromass culture, the expression of ITGA3 on Day 0 was five times less than in untreated 
hMSCs and this value is similar to those found in pellet culture and collagen type II gels on Day 2, this 
similarity might be explained by the protocol to forme micromass. Cells are thus cultured at high 
density before what was stated as Day 0 in this experiment and might explained the shift we 
observed when expression in micromass is compared to expression in pellet culture and collagen 
type II gels. Here again the expression of ITGA3 was overall higher in growth conditions compared to 
expression in cells cultured in chondrogenic medium. 
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Figure 17 – ITGA3 expression over time in pellet 
culture (A), micromass culture (B) and collagen type 
II gels (C). Expression of ITGA5 is shown relative to 
untreated hMSCs expression cultured on tissue 
culture plastic. The expression between 
chondrogenic and control conditions was 
significantly different,  ITGA3 was always expressed 
in higher amount in control condition than in 
chondrogenic conditions. Moreover similar ITGA3 
expression levels were found in each method on Day 
21 in control conditions. (N=3 independent 
experiments, mean ± standard error.) 
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ITGA4: 
Throughout the 21 days, ITGA4 always more expressed in hMSC cultured in growth medium than 
hMSC undergoing chondrogenesis in all three different culture methods (Figure 18). Furthermore, 
the expression variations followed similar patterns between growth and chondrogenic conditions. 
However from Day 4 to Day 21 in micromass culture and collagen II gels there is noticeable 
difference in expression between these conditions, ITGA4 being importantly less expressed in 
chondrogenic conditions compared to growth conditions. These differences were statistically 
significant in collagen II 3D gels, but not in micromass due to high variability between samples within 
the same day. Yet the same trend is graphically observed. Both in pellet culture and collagen II gels 
the expression changes throughout the differentiation can be divided into two steps: an initial 
downregulation in both conditions from an expression initially similar or double the expression found 
in untreated hMSCs to values up to 8 times lower than in untreated hMSCs on Day2, the second 
steps is the upregulation of ITGA4 from Day 2 until the end of experiment. While in pellet culture and 
collagen type II gels, ITGA4 expression was similar to untreated hMSCs on Day 0, in micromass 
culture the expression was found 4 times lower, which are values found on Day 2 in the two other 
culture models. Interestingly the final expression levels were similar in growth condition throughout 
the three different methods with values oscillating between -1.7 and +1-time fold expression in 
untreated hMSCs and between -2.7 and -5.85 in chondrogenic medium. Finally overall expression 
was found higher in cells cultured in growth medium than in cells undergoing chondrogenesis. 
  
 
 
 
 
 
 
 
 
 
 
  
-10
-8
-6
-4
-2
0
2
4
Day 0 Day 1 Day 2 Day 4 Day 7 Day 14 Day 21
E
xp
re
ss
io
n
 r
e
la
ti
ve
 t
o
 h
M
SC
s 
cu
lt
u
re
d
 o
n
 T
C
P
-6
-5
-4
-3
-2
-1
0
Day 0 Day 1 Day 2 Day 4 Day 7 Day 14 Day 21
E
x
p
re
ss
io
n
 r
e
la
ti
v
e
 t
o
 h
M
S
C
s 
cu
lt
u
re
d
 o
n
 T
C
P
-12
-10
-8
-6
-4
-2
0
2
4
Day 0 Day 1 Day 2 Day 4 Day 7 Day 14 Day 21
E
xp
re
si
o
n
 r
e
la
ti
ve
 t
o
 h
M
SC
s 
cu
lt
u
re
d
 o
n
 T
C
P
C 
A B 
Figure 18 - ITGA4 expression in pellet culture (A), 
micromass culture (B) and collagen type II gels (C). 
Expression of ITGA5 is shown relative to untreated
hMSCs expression cultured on tissue culture plastic. 
Expression was significantly different from its initial 
state on Day 0 in pellet and collagen type II gels. (N=3 
independent experiments, mean ± standard error.) 
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ITGA5: 
ITGA5 expression in growth conditions remained stable in the three methods, indeed its level 
oscillate at similar expression levels found in untreated hMSCs cultured on TCP (Figure 19). While in 
chondrogenic conditions the expression variations were different depending on the method: 
 In pellet culture, ITGA5 was continuously downregulated throughout the differentiation 
process. 
 In micromass culture ITGA5 was initially slightly upregulated followed by a downregulation 
after Day 4 to eventually reach the same expression level than in growth conditions. Yet 
these variations are little and not significant.  
 In collagen II gels, expression in cells undergoing chondrogenesis the remained stable until 
Day 4 from which it started to be greatly downregulated, on Day 14 and 21 expression was 
12 time lower than in untreated hMSCs. 
Interestingly, the expression of ITGA5 on Day 0 of micromass culture was 2-time lower than 
expression in untreated hMSCs and this value correspond to expression level found both in pellet 
culture and collagen type II gels on Day 2, this might be due to the 48 hours time shift. Moreover in 
pellet culture and collagen gels the expression of ITGA5 in chondrogenic conditions was found much 
lower than the expression in growth conditions. The expression pattern was significantly different 
over time between the growth and chondrogenic conditions in micromass culture and in collagen 
gels. 
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Figure 19 – ITGA5 expression over time in pellet culture (A), 
micromass culture (B) and collagen type II gels (C). 
Expression of ITGA5 is shown relative to untreated hMSCs 
expression cultured on tissue culture plastic. Expression 
remained constant in control conditions with similar values 
than untreated hMSCs, however in chondrogenic medium 
expression pattern where different depending on culture 
method. (N=3 independent experiments, mean ± standard 
error.) 
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ITGA6:  
ITGA6 showed dissimilar expression pattern according to the culture methods. In pellet culture, 
ITGA6 expression was firstly slightly downregulated in growth conditions then reached a plateau on 
Day 1, while in chondrogenic medium expression was importantly downregulated, moreover the 
differences among the two conditions were significant (Figure 20). On the other hand, in micromass, 
ITGA6 expression in growth and in chondrogenic condition varied in correspondingly characterised by 
a continuous increase, and the expression levels were similar at each time point. Interestingly, the 
level of expression of ITGA6 found on Day 0 in micromass culture, approximately 15-times less 
expressed than in untreated hMSCs, was similar to the expression found on Day 2 in the two other 
culture models, this is explained by the 48 hours shift for micromass formation by gravity. In collagen 
type II gels, the high variability were found between the samples along with missing data on Day 14 
and Day 21 in chondrogenic conditions does not allow any conclusion. Finally, here again in growth 
conditions the expression levels in all three methods converged toward a similar values on Day 21 
which is about -3 times expression in untreated hMSCs, this level of expression was reach from Day 1 
in pellet culture, from Day 2 in micromass culture and from Day 7 in collagen gels.  
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Figure 20 - ITGA6 expression over time in pellet culture 
(A), micromass culture (B) and collagen type II gels (C). 
Expression of ITGA6 is shown relative to untreated
hMSCs expression cultured on tissue culture plastic. 
Day 0 expression found in micromass culture 
correspond to Day 2 expression level in both pellet 
culture and collagen type II gels. (N=3 independent 
experiments, mean ± standard error.) 
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ITGA7:  
No clear expression pattern could be identified for ITGA7 between the different culture models 
(Figure 21). However in pellet culture and in micromass culture, expression in growth and 
chondrogenic conditions varied identically. In pellet culture, an initial downregulation from Day 0 to 
Day 2 followed by an upregulation until Day 14 and a final decrease on Day 21. No significant 
differences are seen between growth and chondrogenic conditions, and no significant expression 
changes were noticed compared to initial state Day 0. Similarly, in micromass culture no differences 
were observed between the growth and chondrogenic conditions, moreover expression in control 
and in chondrogenic conditions varied in correspondingly. It seems that ITGA7 expression is not 
affected at all by the chondrogenic differentiation. No significant conclusion was possible, neither in 
collagen II gels were the last two time points are missing for hMSC undergoing chondrogenesis. The 
expression pattern was not significantly different over time between the growth and chondrogenic 
conditions in any culture system. 
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Figure 21 - ITGA7 expression over time in pellet culture 
(A), micromass culture (B) and collagen type II gels (C). 
No clear expression of ITGA7 could be identified 
between the different culture methods, control and 
chondrogenic conditions do not seem to have any 
effect on ITGA7 expression. (N=3 independent 
experiments, mean ± standard error.) 
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ITGA10:  
ITGA10 had a similar expression pattern between pellet culture and collagen type II gels, indeed in 
both methods the expression in growth conditions was significantly downregulated compared to Day 
0 at early stages followed by an important upregulation after Day 4 (Figure  22). Moreover in 
chondrogenic conditions the expression remained relatively unchanged. In micromass culture, both 
growth and chondrogenic the same expression pattern was identified characterised by an initial 
upregulation at similar rate followed by a downregulation which was greater in chondrogenic 
conditions resulting in an overall higher expression in growth conditions, however the variability was 
particularly important in micromass and did not lead to any conclusive results. It is interesting to 
notice that Day 0 expression level in micromass culture is similar to Day 2 expression level in pellet 
and micromass culture, here again the expression pattern of micromass might be shifted by 48 hours 
due to the process of micromass formation. In the three different methods the expression was higher 
in growth than in chondrogenic conditions. The expression profile over time was significantly 
different between the growth and chondrogenic conditions in pellet culture and in collagen gels, but 
not in micromass culture due to a high variability. 
  
 
 
 
 
 
 
 
 
 
 
 
  
-4
-2
0
2
4
6
8
10
12
14
16
Day 0 Day 1 Day 2 Day 4 Day 7 Day 14 Day 21
E
xp
re
ss
io
n
 r
e
la
ti
ve
 t
o
 h
M
SC
s 
cu
lt
u
re
d
 o
n
 T
C
P
0
5
10
15
20
25
30
35
40
45
Day 0 Day 1 Day 2 Day 4 Day 7 Day 14 Day 21
E
x
p
re
ss
io
n
 r
e
la
ti
v
e
 t
o
 h
M
S
C
s 
cu
lt
u
re
d
 o
n
 T
C
P
0
5
10
15
20
25
30
35
40
45
Day 0 Day 1 Day 2 Day 4 Day 7 Day 14 Day 21
E
xp
re
si
o
n
 r
e
la
ti
ve
 t
o
 h
M
SC
s 
cu
lt
u
re
d
 o
n
 T
C
P
Figure  22 - ITGA10 expression over time in pellet culture 
(A), micromass culture (B) and collagen type II gels (C). 
Expression of ITGA10 is shown relative to untreated hMSCs 
expression cultured on tissue culture plastic. Similar 
expression pattern were observed between pellet culture 
and collagen type II gels for both control and chondrogenic 
conditions, micromass expression pattern seem to be the 
same than in the two other models but shifted by 48 
hours. (N=3 independent experiments, mean ± standard error). 
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ITGA11:  
ITGA11 was one of the two alpha subunits where expression was found higher in chondrogenic 
conditions than in growth conditions, and even if this difference was not significant this trend was 
however found in the three culture models (Figure 23). Indeed the expression profile over time was 
not significantly different between the growth and chondrogenic conditions in any of the culture 
systems. Moreover the expression pattern of ITGA11 in hMSCs in growth conditions and those 
undergoing chondrogenesis was similar, and a significant gradual upregulation was observed in the 
three models for both conditions. In pellet culture, stable expression level were observed until Day 7 
were an important increase in expression occurred in both condition. In micromass culture, the 
expression was continuously and greatly upregulated. Overall the expression pattern was similar 
between growth and chondrogenic conditions with a slightly higher expression in chondrogenic 
conditions. Finally, in collagen gels the expression did not change importantly however a continuous 
increase was noticed. 
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Figure 23 - ITGA11 expression over time in pellet culture 
(A), micromass culture (B) and collagen type II gels (C). 
Expression of ITGA11 is shown relative to untreated 
hMSCs expression cultured on tissue culture plastic. 
Expression of ITGA11 was significantly upregulated in the 
three different culture models, the expression was always 
higher in control versus chondrogenic condition. (N=3 
independent experiments, mean ± standard error). 
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ITGAV:  
ITGA11 was the second alpha subunit where expression was found to be higher in chondrogenic 
conditions over growth conditions in all three methods. Yet the expression pattern was different 
according to the culture methods (Figure 24). In pellet culture, the variations in expression levels 
remained small, characterised by an initially downregulation followed by a significant upregulation 
after Day 2 in both growth and chondrogenic conditions. In micromass, expression was significantly 
increased in a continuous manner in both conditions however the increase was more important in 
hMSCs undergoing chondrogenesis. In collagen type II gels, ITGAV expression remained stable in 
chondrogenic conditions while in growth conditions it was significantly downregulated at early time 
points, followed by an upregulation to reach the same expression level than in chondrogenic 
conditions on Day 21. Importantly in the three culture models, the expression level of ITGA11 in 
growth and chondrogenic conditions converge to a similar level on Day 21. Furthermore the ITGA11 
expression was overall higher in hMSCs undergoing chondrogenesis than hMSCs cultured in growth 
medium. 
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Figure 24 - ITGAV expression over time in pellet culture 
(A), micromass culture (B) and collagen type II gels (C). 
Expression of ITGAV is shown relative to untreated 
hMSCs expression cultured on tissue culture plastic.  
Expression of ITGAV expression was higher in 
chondrogenic conditions than control conditions. (N=3 
independent experiments, mean ± standard error.) 
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4.2.5. Expression of Beta Integrin Subunits in the Different Culture Systems 
ITGB1: 
The expression of the β1 subunit was very similar between growth and chondrogenic conditions 
(Figure 25). In pellet culture and collagen type II gels, the expression pattern of ITGB1 can be divided 
in two steps: the first step is characterized by a downregulation from Day 0 to Day 1 at similar rate 
between the growth and chondrogenic conditions in both culture models. The second step occurs 
from Day 2 until the end of the experiment and is chacterized by an upregulation in the two 
conditions. 
In micromass culture the expression seems to be only upregulated, yet probably that first step of the 
expression pattern which is the downregulation occurred during the 48 hours necessary for the 
spontaneous formation of the micromass and thus is seen, only the second step of the pattern is 
identified from Day 2 which is the upregulation of ITGB1 expression. 
The expression profile of ITGB1 was not significantly different over time between the growth and 
chondrogenic conditions in micromass and pellet culture, but was different in collagen gels. 
   
 
 
 
 
 
 
 
 
 
 
  
-6
-5
-4
-3
-2
-1
0
1
2
Day 0 Day 1 Day 2 Day 4 Day 7 Day 14 Day 21
E
xp
re
ss
io
n
 r
e
la
ti
ve
 t
o
 h
M
SC
s 
cu
lt
u
re
d
 o
n
 T
C
P
-6
-4
-2
0
2
4
6
8
Day 0 Day 1 Day 2 Day 4 Day 7 Day 14 Day 21
E
x
p
re
ss
io
n
 r
e
la
ti
v
e
 t
o
 h
M
S
C
s 
cu
lt
u
re
d
 o
n
 T
C
P
-4
-3
-2
-1
0
1
2
3
Day 0 Day 1 Day 2 Day 4 Day 7 Day 14 Day 21
E
xp
re
si
o
n
 r
e
la
ti
ve
 t
o
 h
M
SC
s 
cu
lt
u
re
d
 o
n
 T
C
P
C 
A B 
Figure 25 - ITGB1 expression over time in pellet culture 
(A), micromass culture (B) and collagen type II gels (C).  
Expression of ITGB1 is shown relative to untreated hMSCs 
expression cultured on tissue culture plastic. Micromass 
culture expression pattern of ITGB1 seems to be shifted of 
48 hours compare to the two other culture methods.  (N=3 
independent experiments, mean ± standard error). 
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ITGB3 : 
Data are missing for the latest time points for the three methods, yet an important downregulation is 
observed on Day 14 in hMSCs undergoing chondrogenesis and this is true for the three culture 
models (Figure 26). Cells cultured in growth conditions had a constant expression of ITGB3, while in 
chondrogenic conditions ITGB3 expression was downregulated, however these differences in 
expression level were not statistically different, this might be due to some data points that are 
lacking. The expression pattern of ITGB3 over time was not significantly different between the 
growth and chondrogenic conditions in any of the culture systems. Overall expression of ITGB3 was 
higher in growth conditions compared to chondrogenic conditions. 
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Figure 26 – ITBG3 expression over time in pellet 
culture (A), micromass culture (B) and collagen type II 
gels (C).  Expression of ITGB3 is shown relative to 
untreated hMSCs expression cultured on tissue culture 
plastic. (N=3 independent experiments, mean ± standard 
error). 
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ITGB5: 
The expression of ITGB5 follows the same pattern in pellet culture and collagen type II gels for both 
condition which are growth and chondrogenic medium, which is characterized by an initial 
downregulation from Day 0 to Day 1, followed by a plateau between Day 1 and Day 2, and an 
upregulation from Day 2 onwards (Figure 27). In the two culture models, the upregulation was more 
important in growth conditions than chondrogenic conditions. In micromass, the expression pattern 
of ITB5 follows the one seen in pellet culture and collagen II gels from Day 2: an upregulation in both 
conditions, however an higher increase in growth over chondrogenic conditions. Again this shift in 
time for the expression pattern might be linked to the 48 hours necessary for the formation of 
micromass. The expression profile of ITGB5 was significantly different over time between the growth 
and chondrogenic conditions in the three methods. 
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Figure 27 - ITBG5 expression over time in pellet culture 
(A), micromass culture (B) and collagen type II gels (C). 
Expression of ITGA11 is shown relative to untreated 
hMSCs expression cultured on tissue culture plastic. 
Similar expression pattern is observed in pellet and 
collagen type II gels, which is also found in micromass 
culture with a shift of 48h. (N=3 independent 
experiments, mean ± standard error). 
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ITGB8: 
In the three different culture methods, the expression of ITGB8 was greatly increased in growth 
conditions while remained constant in chondrogenic conditions, except for collagen II gels where 
expression in hMSCs undergoing chondrogenesis was also continuously upregulated (Figure 28). 
Indeed in growth conditions, ITGB8 expression was increased up to 50 times expression level found 
in untreated hMSCs. The expression profile over time was significantly different between the growth 
and chondrogenic conditions in pellet culture and in micromass culture, but not in collagen type II 
gels due to the important variability of the expression of ITGB8 within the same group of samples. 
Overall expression of ITGB8 in growth conditions were much higher than in chondrogenic conditions. 
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Figure 28 - ITGB8 expression over time in pellet culture 
(A), micromass culture (B) and collagen type II gels (C).  
In each methods the expression was greatly increase in 
control conditions, yet these variations were not 
significant in micromass culture and collagen type II 
gels mainly due to important standard deviation. (N=3 
independent experiments, mean ± standard error). 
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5. Discussion 
The aim of the project is to establish a transcript expression profile for each integrin subunits in 
different culture systems during hMSC chondrogenesis. Cartilage tissue engineering struggles to 
produce stable chondrocyte and integrins are major intermediates between cells and the ECM, 
establishing their expression pattern throughout chondrogenic differentiation would provide an 
improved knowledge about the adhesion requirements but also about the integrin-triggered 
intracellular signalling required for the differentiating cells.  
 
5.1. Statistical Significance 
In this study, we performed two tailed t-test between the growth and chondrogenic conditions for 
each method on each day. We also performed two-way ANOVA in order to determine if the 
transcript expression between the growth and chondrogenic conditions was significantly different 
over time. However although graphically the behaviour between these two conditions was clearly 
distinct, statistical significance was not always established. This was mainly due to variability in 
expression within the same day between the three independent experiments for each culture 
methods in either growth or chondrogenic conditions. In the present study, we were more interested 
in showing trends in expression pattern of the different integrins subunits between different culture 
models. 
 
5.2. Chondrogenesis: Comparison Between Different Culture Systems 
We first wanted to determine the relative success of chondrogenesis in our three culture systems. 
The qPCR data and histology staining revealed that the overall collagen deposition and mRNA 
expression, which includes collagen types I, II and X, was greater in pellet culture than in the other 
culture methods. Collagen staining by Sirius red was weaker in micromass culture compare to pellet 
culture and finally the collagen II hydrogels showed the lowest overall collagen expression. 
Moreover, pellet culture showed also the higher COL2A1 expression reaching up to 1.4-times GAPDH 
expression level on Day 21. In collagen gels, expression reached 0.8-time GAPDH expression but was 
only of 0.27-time GAPDH expression in micromass culture. However COL2A1 expression was 
detected earlier in collagen gels than in pellet culture. COL1A1, characteristic of fibrocartilage, was 
16 and 11-times higher COL2A1 in pellet culture and collagen II gels on Day 21. In micromass culture, 
COL1A1 was over 100 times more expressed than COL2A1. For the third type of collagen quantified, 
COL10A1, pellet expression reached 15-times GAPDH expression on Day 21, compare to only 
5.5.times and 2-times GAPDH expression in collagen gels and micromass respectively. In conclusion, 
micromass culture showed the higher COL1A1 expression and the lower COL2A1, the collagen RNA 
being produced suggests that the cell may be producing an ECM more characteristic of fibrocartilage 
than hyaline cartilage. On the other hand, pellet culture showed the greatest overall collagen 
deposition and COL2A1 expression (Table 8), however it also had the higher COL10A1 suggesting that 
chondrocytes might eventually undergo hypertrophy. Finally in collagen type II gels, the collagen 
deposition was the lowest when looking at collagens expression, yet relatively to COL2A1 it 
expressed less COL1A1 and COL10A1 than in pellet and micromass culture. 
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Table 8 - Collagen types I and X relative expression to Collagen type II expression 
 Pellet culture      Micromass culture    Collagen type II gels 
abcLdL
abcedL 	fghifjjklm 16 115 11 
abcLFdL
abcedL 	fghifjjklm 11 7 7 
 
Concerning the chondrocyte phenotype markers ACAN and SOX9, no significant differences were 
noticed between cells grown in growth or chondrogenic medium. SOX9 is an early chondrogenic 
transcription factor which has been shown to activate COL2A1 and ACAN expression, its expression 
was slightly upregulated in all the methods in both conditions and this weak upregulation seems to 
be sufficient to support matrix production. In micromass culture, ACAN expression tended to 
increase over time, while in the two other culture models its expression was downregulated. 
Although investigating chondrocyte phenotype markers expression investigation by qPCR did not 
show upregulation as expected during chondrogenesis, histology confirmed accumulation of 
proteoglycans in the extracellular environment by a bright alcian blue staining. Finally it is also 
important to highlight the fact that PPARγ was never expressed, and that RUNX2 expression levels 
remained very low. The hMSCs are thus not committed to either adipogenic or osteogenic fates; 
some rare cells might undergo osteogenesis as shown by the low level of RUNX2 however it would be 
a negligible fraction. 
 
5.3. Time-shift in Integrin Transcript Expression Pofile in Micromass 
Culture 
The formation of micromass involves incubating the cells in growth medium in a round bottom well 
of a 96-well plate such that the micromass spontaneously forms within 48 hours by falling due to 
gravity cells then reinforce the interactions by forming cell-cell contacts, Day 0 was defined as when 
medium was changed for chondrogenic medium, hence cells are exposed to a high cellular density 
system which promotes chondrogenic differentiation 48 hours prior the experimental official Day 0. 
This might result in a time-shift of 24-48 hours in integrin expression in micromass culture versus 
pellet culture and collagen type II 3D hydrogels. Indeed for several integrin subunits, a similar 
expression pattern was not identifiable between the three culture methods due to this time-shift, for 
some integrins subunits a 24 to 48 hours shift should be taken into consideration in order to 
recognise an expression pattern between the models. 
We are fairly confident that a time shift is being observed in expression of the integrin subunits α3, 
α4, α6 and β1. A downregulation of integrin subunits α3, α4 and α6 is seen from Day 0 to Day 2 
which is followed by an upregulation from Day2 onwards in both pellet culture and in collagen type II 
gels, however the initial downregulation is not seen in micromass culture probably due to the 48 
hours time-shift. Furthermore the expression pattern of α3, α4, α6 and β1 in micromass follows the 
expression pattern in the two other culture models after Day 2. Concerning integrin subunit α5 and 
α10 expression level on Day 0 in micromass might correspond to Day 2 in pellet culture and collagen 
type II gels however after Day 2 the expression pattern did not follow, hence it is not possible to 
affirm if a time-shift occurred in the expression of these two integrin subunits. 
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5.4. Integrin Subunits Expression 
The most interesting approach to analyse the expression profile of integrins during chondrogenesis is 
to look at integrin subunits transcript expression evolution according to their ligand affinity. Hence 
we will discuss about the integrin expression profile variations for the alpha subunits related to the 
collagen-, fibronectin- and laminin-binding integrins separately. 
5.4.1. Integrins Receptors for Collagen 
Collagen constitutes one of the major component of cartilage. The four primarily collagen-binding 
integrins are α1β1, α2β1, α10β1 and α11β1, they are known to be widely expressed on 
chondrocytes. As the alpha subunits α1, α2, α10 and α11 are only associated with β1 and not any 
other beta subunit, the alpha subunits expression is directly representative to the corresponding 
integrin expression. Furthermore the expression pattern of integrin and the ligand affinity of the 
integrin defines the adhesive property of the cell. 
The integrin subunit α1 expression was stable in chondrogenic medium while greatly upregulated in 
growth conditions in all three culture methods compared to untreated hMSCs cultured on tissue 
culture plastic. Conversely, the expression of integrin subunit α2 was stable in growth conditions but 
importantly downregulated in hMSCs undergoing chondrogenic differentiation. Similar to the 
integrin subunit α1, α10 was also highly upregulated in growth conditions, and remained stable 
during chondrogenesis in pellet culture and collagen type II gels while also upregulated in micromass. 
Finally, the integrin subunit α11 expression was upregulated in both conditions, yet more 
importantly in chondrogenic conditions resulting in an overall higher expression in hMSCs 
undergoing chondrogenesis. With the exception of α11, the three other alpha subunits expression 
was higher in growth conditions over chondrogenic conditions. Taken together these data suggest 
that cells undergoing chondrogenesis are less adhesive to collagen than cells grown in growth 
medium. The integrin α1β1 is a primary chondrocyte collagen type VI receptor and collagen type IV, 
however it also binds to a lower extent to collagen types I, II.
74
 The integrin α2β1 binds preferentially 
collagen type I, yet it is also a receptor for collagen type IV, VI.  α10β1 integrin binds mostly collagen 
type IV, then type VI and type II with a lower affinity. The last collagen-binding integrin α11β1 is 
primary receptor for collagen type I, but it also binds to type IV. Finally, these four integrins are also 
receptor for collagen type IX.
56
 From the data obtained in the present study, the cells culture in 
growth conditions in the three methods increased over time their overall adhesive properties to 
collagens, Table 9 summarises the change in adhesion properties of hMSCs cultured in growth 
medium. 
Table 9 - Adhesion properties of hMSCs cultured in growth medium. The overall adhesion to collagen type I, II, IV, VI and IX 
was enhanced over the time period of 21 days as the integrin α subunits related to collagen receptors are all upregulated. 
Collagen type 
Adhesion to 
collagen 
Justification 
Collagen type VI Increased Upregulation of α1 and α11 
Collagen type IV Increased Upregulation of α1, α10 and α11 
Collagen type IX Increased Upregulation of α1, α10 and α11 
Collagen type II Increased Upregulation of α1 
Collagen type I Increased Upregulation of α1, 
Unchanged expression of α2 
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It is more difficult to derive any conclusion for hMSCs undergoing chondrogenesis about adhesion 
variations over time as the alpha subunit of both primary collagen I binding integrins, α1β1 and 
α11β1, were regulated in an exact opposite manner: α2 was downregulated while α11 was 
upregulated. Expression of integrin subunits α1 and α10 remained unchanged. Hence no conclusion 
is possible about adhesion to collagen type I, IV and IX, however it suggests that adhesive property 
remained unchanged. Table 10 summarises the main change in adhesion requirement in hMSCs 
undergoing chondrogenesis. 
Table 10 - Adhesion properties of hMSCs cultured in chondrogenic medium. No statement was possible about change in 
adhesion properties for collagen types I, IV and IX, adhesion to collagen type II remains unchanged as expression of both 
integrin subunits α1 and α10 while adhesion to collagen type VI decrease due a downregulation of integrin subunit α2. 
Collagen type 
Adhesion to 
collagen 
Justification 
Collagen type II unchanged α1 and α10 remained unchanged 
Collagen type VI decreased downregulation of α2. 
 
The expression of integrin receptors for collagen was increased over time in hMSCs culture in growth 
medium which implies an enhanced adhesion to these ECM molecules, while in hMSCs undergoing 
chondrogenesis overall adhesion over time remained stable due to unchanged integrin expression or 
counter regulated expression.  
Varas et al. investigated the expression of integrins subunits α1, α10 and α11 and stated that during 
chondrogenesis in aggregate culture α1 and α11 are downregulated while α10 is upregulated.63 
These results are quite different from our data as α1 and α10 remained stable, and α11 was 
upregulated. However we observed an important increase of integrin subunit α10 expression in 
growth conditions. Loeser et al. showed that β1-integrins expression were upregulated in monolayer 
culture and alginate culture which in turn increase the adhesion properties of the cells, this 
upregulation was also observed in osteoarthritic cartilage compare to normal cartilage, and the 
greatest increase was observed for α1β1 integrin.74 The important increase of integrin subunit α1 
observed in our cell culture studies in growth conditions seems to be a feature of osteoarthritic cells, 
the fact that in chondrogenic condition the expression of α1 remained constant is encouraging. 
Furthermore, α2 expression was importantly downregulated in chondrogenic medium while 
remaining stable in growth conditions. This behaviour is not consistent with and Varas et al. study 
where α2 expression remained unchanged in cells undergoing chondrogenesis, yet in Goessler et al. 
study α2 expression was downregulated.75 Moreover, integrin subunit α2 was not found significantly 
expressed in articular chondrocytes, and integrin α2β1 is known to more expressed in 
chondrosarcoma relative to normal adult chondrocytes.
74
  
5.4.2. Integrins Receptors for Fibronectin, Vitronectin and Osteopontin 
Fibronectin is a common extracellular matrix component in native cartilage tissue. Several integrins 
binds to fibronectin: integrins α4β1 and α4β7 recognise the LDV tripeptide found in fibronectin, 
while α5β1, αVβ1, αVβ3, αVβ6, αVβ5, αVβ8 recognise the RGD sequence. These integrins are not 
only receptor for fibronectin, they bind numerous other ligands among Osteopontin, COMP, 
vitronectin, tenascin etc. The beta subunits β6 and β7 were not expressed, hence we are only 
considering the following integrins: α4β1, α5β1, αVβ1, αVβ3, αVβ5, and αVβ8.  
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Interestingly the integrin subunits α4, α5, and αV present in the heterodimeric integrin receptors for 
fibronectin were the alpha subunit for which an expression pattern was not discernible between the 
three different culture methods we investigated. Indeed the expression of these three alpha subunits 
seemed to be highly variable and dependent on the culture model. 
In pellet culture and collagen type II gels, α4 expression was initially greatly downregulated in 
chondrogenic conditions but was then increased again from Day 4, it seems that the fibronectin 
adhesion through the α4β1 integrin at early stages is diminished but then is increased again after 
Day 4. α4 is normally not expressed in normal adult articular chondrocytes, however in another study 
it’s expression during chondrogenesis in pellet culture was tripled on D20 compared to D0.
74,75
 In our 
cell culture study, α4 was overall downregulated in chondrogenic conditions, particularly on D1 and 
D2 in pellet culture and collagen type II gels before being slightly upregulated. Its expression was 
found relatively stable in growth conditions. α5β1 integrin is known to be the primary chondrocyte 
fibronectin receptor,
60
 α5 expression remained stable in hMSCs undergoing chondrogenesis up to 
Day 7 in pellet culture and collagen type II gels, however on Day 14 and on Day 21 the expression of 
α5 was dramatically downregulated which implies a decreased adhesion to fibronectin via α5β1 
integrin on late stages of chondrogenesis. This is consistent with another study where α5 subunit 
expression was also decreased however at a lower extent.
75
 The expression pattern in chondrogenic 
environment in micromass was completely different, indeed the expression α5 was upregulated from 
D0 to D1. The plateau was maintained until Day 4 where the expression was decreased to a similar 
level than in growth conditions. Integrin α5β1 is known to be highly expressed on articular 
chondrocytes in situ and in vitro. Concerning the expression pattern of integrin subunit αV was here 
again depending on the culture method, however it is interesting to note that αV was more 
expressed in chondrogenic conditions than in growth conditions. Importantly, αV-containing 
integrins bind to vitronectin and osteopontin primarily and may serve as secondary fibronectin 
receptors. 
Throughout the three culture models, α4 and α5 integrin subunits were more expressed in cells 
cultured in growth medium than in cells cultured in chondrogenic medium. Oppositely integrin 
subunit αV as found more expressed in cells culture in chondrogenic conditions. From these data, we 
can hypothesise that adhesion to fibronectin for cells cultured in growth medium occurs 
preferentially through α4β1 and α5β1 integrins, while for cells cultured in chondrogenic medium the 
adhesion to vitronectin and osteopontin via αV-containing integrins is more important. The αV-
containing are αVβ1, αVβ3, αVβ5, and αVβ8, as β6 was not expressed. 
5.4.3. Integrins Receptors for Laminin 
The integrins α3β1, α6β1 and α7β1 are highly specific laminin receptors.  α3β1 is also known to be a 
secondary receptor for fibronectin and collagen type II and α7β1 was recently proposed as a 
receptor for COMP.
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The expression α3 was dependant on the methods of culture, however overall we observed a 
downregulation throughout time in chondrogenic environment which is consistent with the findings 
of Varas et al. in aggregate culture.
63
 At early stages, the expression of integrin subunit α3 was the 
same in growth or in chondrogenic conditions, however on Day 7, 14 and 21 an important 
downregulation was noticed in chondrogenic conditions compare to growth conditions, this was 
consistent in the three culture models. Hence the adhesive properties to laminin via the α3β1 
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integrin of the cells undergoing chondrogenesis seems to be decreased on late stage of 
differentiation compare to cells cultured in growth medium. 
Concerning the integrin subunits α6, its expression pattern was highly variable depending upon the 
culture systems, indeed if its expression was downregulated in pellet culture it was found to be 
upregulated in micromass culture. Furthermore similar different behaviour was observed between 
the growth and chondrogenic conditions, because of this lack of divergence we believe that the 
integrin subunits α6 might not have a vital role in chondrogenesis. This hypothesis was also relevant 
for integrin subunit α7, indeed expression was identical between growth and chondrogenic 
conditions, whenever a variation occurred it was found in both conditions. Goessler et al. did not 
detect α6 nor α7 in their study during chondrogenesis and also concluded that the role of these 
integrin subunits was not important in chondrogenesis.
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5.4.4. Integrin Beta Subunits 
The beta subunits β1, β3, β5, and β8 were expressed in hMSCs cultured in growth and in hMSCs 
cultured in chondrogenic medium. β2, β4, β6 and β7 were not detected. 
The expression variations of beta subunits β1, β3, and β5 remained small which is consistent with 
other studies were expression of these subunits remained unchanged. Expression of β3 was 
downregulated on Day 14 and Day 21 in chondrogenic conditions, β3 is the beta component of two 
integrins αVβ3 and αIIbβ3 recognising the RGD tripeptide sequence, they are both fibronectin 
receptors. β5 is the beta component of only one integrin: αVβ5 which is known to bind osteopontin 
and vitronectin, its expression remained stable in chondrogenic condition but was initially 
downregulated followed by an upregulation in hMSCs cultured in growth medium. Once could think 
that this expression pattern would be similar for αV, however it is not the case as αV binds five 
different beta subunits. 
The integrin subunit β1 expression was similar between hMSCs cultured in growth or in chondrogenic 
medium. Overall its expression remained stable, in pellet culture and collagen type II gels an initial 
downregulation followed by an upregulation was identified in both culture medium conditions. β1-
integrins is a large family composed of 12 members: α1β1, α2β1, α3β1, α4β1, α5β1, α6β1, α7β1, 
α8β1, α9β1, α10β1, α11β1, and αVβ1, they recognise numerous different ligands. It is thus not 
surprising to see little changes in its expression. 
The only beta subunit were great expression changes were observed was β8, indeed its expression 
was importantly and continuously increased in hMSC cultured in growth medium. The β8 subunit 
associates with αV subunit to form αVβ8 integrins which is a receptor for vitronectin. We initially 
hypothesise that vitronectin adhesive properties are greatly increased via αVβ8 in hMSCs cultured in 
growth conditions however the expression of αV remained stable in growth conditions, further 
investigation with adhesion experiment would need to be performed in order to address this 
question. 
5.4.5. Integrins Subunits Not Expressing During Chondrogenesis 
As aforementioned we investigated expression of all the integrin subunits however several were not 
expressed during the chondrogenesis, those are α8, α9, αD, αE, αL, αM, αW and αX for the alpha 
subunits and β2, β4, β6 and β7 for the beta subunits. 
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β2-integrins are leukocytes-specific receptors, this subgroup includes αDβ2, αLβ2, αMβ2, and αXβ2, 
their expression is restricted to leukocytes hence it is normal that their expression was not detected 
in any of our culture system. The integrin αEβ7 is also a leukocyte-specific receptor.2 Concerning the 
other integrin subunits not detected in our culture systems, including α8, α9, αW and β4, they were 
not expressed, to our knowledge, neither in other studies about hMSCs undergoing chondrogenesis. 
Indeed for instance, in Varas et al. study about integrin subunit during chondrogenic differentiation 
β2 and β6 were not detected neither.63 
5.4.6. Future Work 
Establishing integrins subunits transcript profile during chondrogenesis has provided a considerable 
knowledge about the adhesion requirements of the differentiating hMSCs but also about which 
integrins might play an important role to promote differentiation. Further investigations would need 
to done in order to assess the hypothesis about important integrins for chondrogenesis, 
disregulation of integrin signalling by using antibodies against specific subunit would provide useful 
information. Moreover, comparing the integrin subunits expression profile to expression in freshly 
isolated human chondrocytes might provide some interesting information. Additionally, the 
knowledge acquire about the adhesive properties of the differentiating hMSCs can be interpreted in 
order optimise biomaterials for cartilage tissue engineering from a chemical and biological 
perspective by presenting for instance a set of ligands according to the changing adhesion 
requirements of the hMSCs undergoing chondrogenesis. 
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Expression 
changes in 
growth medium 
Expression 
changes in 
chondrogenic 
medium 
Integrin ligands affinity 
Notes 
ITGA1 
Highly 
upregulated 
Stable 
α1β1 
 primary chondrocyte receptor for 
collagen VI > collagen II 
 affinity collagen IV > collagen I 
 collagen IX 
 Important variations in expression levels were observed. 
 From literature: 
- Expression of ITGA1 decreased in aggregate culture.
63
 
- High expression on adult articular chondrocytes.
74
 
- Expression of ITGA1 Day 20/Day 0 was 0.63 in pellet culture.
75
 
ITGA2 Stable 
Highly 
downregulated 
α2β1 
 affinity collagen I > collagen IV 
 collagen VI (weak) 
 collagen IX 
 Important variations in expression levels were observed. 
 From literature: 
- Expression of ITGA2 unchanged in aggregate culture.
63
 
- ITGA2 is not significantly expressed in adult articular chondrocytes. 
Relative to adult chondrocytes α2β1 expression is higher in 
chondrosarcoma and foetal chondrocytes.
74
  
- Expression of ITGA2 Day 20/Day 0 was 1.3 in pellet culture.
75
  
ITGA3 
Depends on the 
method 
Depends on the 
method 
α3β1 
 Laminin primarily 
 Secondary receptor for collagen II and 
fibronectin 
 Other ligands 
 Time shift in micromass culture. 
 From literature: 
- Expression of ITGA3 decreased in aggregate culture.
63
 
- High expression on adult articular chondrocytes.
74
 
ITGA4 
Depends on the 
method, relatively 
stable. 
Depends on the 
method 
α4β1 
 Fibronectin predominantly 
 Osteopontin 
 Other ligands 
 Time shift in micromass culture. 
 From literature: 
- ITGA4 normally not expressed on adult articular chondrocytes.
74
 
- Expression of ITGA4 Day 20/Day 0 was 3.2 in pellet culture.
75
 
ITGA5 Stable 
Depends on the 
method 
α5β1 
 Primary chondrocyte receptor for 
fibronectin 
 Osteopontin 
 COMP 
 Other irrelevant ligands 
 Time shift in micromass culture. 
 From literature: 
- Expression of ITGA5 unchanged in aggregate culture.
63
 
- High expression on adult articular chondrocytes.
74
 
- Expression of ITGA5 Day 20/Day 0 was 0.78 in pellet culture.
75
 
ITGA6 
Depends on the 
method 
Depends on the 
method 
α6β1 
 Laminin 
 Time shift in micromass culture. 
 From literature: 
- α6β1 is not detected in all studies in adult articular chondrocytes. 
Relative to adult chondrocytes α6β1 expression is higher in 
chondrosarcoma and foetal chondrocytes.
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- Expression of ITGA6 Day 20/Day 0 was 0.64 in pellet culture.
75
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ITGA7 
Unaffected by the culture medium. 
Exact same behaviour in control or in 
chondrogenic medium. 
α7β1 
 Laminin 
 COMP 
 From literature: 
- ITGA7 expression is mostly limited to white blood cells and satellite 
cells
2
 
- Expression of ITGA7 Day 20/Day 0 was 1.7 in pellet culture.
75
 
ITGA10 
Highly 
upregulated 
Depends on the 
method 
α10β1 
 Collagen IV > Collagen VI > Collagen II 
 Collagen IX 
 Laminin 
 Similar trend observed between growth and chondrogenic conditions 
however the upregulation was greater in growth conditions. 
 From literature: 
- Expression of ITGA10 increased in aggregate culture.
63
 
- α10β1 is a primary collagen type II receptor in articular chondrocytes 
and is highly expressed in normal articular chondrocytes.
74
 
ITGA11 
Similar behaviour in control and 
chondrogenic conditions 
  Moderately                      Highly 
  upregulated                upregulated 
α11β1 
 Collagen I > Collagen IV 
 Collagen IX 
 ITGA11 was more expressed in chondrogenic conditions. 
 From literature: 
- Expression of ITGA11 decreased in aggregate culture.
63
 
ITGAV 
Depends on the 
method 
Depends on the 
method 
αVβ1, αVβ3, αVβ5, αVβ6, αVβ8 
 RGD receptors 
 
 ITGAV was more expressed in chondrogenic conditions. 
 From literature: 
- Expression of ITGAV remains unchanged in aggregate culture.
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- αVβ5 is highly expressed in adult chondrocytes while αVβ3 is 
moderately expressed. 
- Expression of ITGAV Day 20/Day 0 was 0.81 in pellet culture.
75
 
ITGB1 
Relatively stable. 
 
Similar behaviour in control and in 
chondrogenic medium. 
α1β1, α2β1, α3β1, α4β1, α5β1, α6β1, 
α7β1, α8β1, α9β1, α10β1, α11β1, and 
αVβ1. 
 See the alpha subunits for ligand 
affinity of the abovementioned 
integrins 
 Time shift in micromass culture. 
 From literature: 
- Expression of ITGB1 remains unchanged in aggregate culture.
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- Expression of ITGAV Day 20/Day 0 was 0.5 in pellet culture.
75
 
ITGB3 Stable 
Initial plateau, 
followed by a 
downregulation 
from Day 14 
onwards 
αVβ1 and αIIbβ1 
 
 From literature: 
- Expression of ITGB3 remains unchanged in aggregate culture.
63
 
ITGB5 
Downregulation 
followed by 
upregulation 
Relatively stable αVβ5 
 From literature: 
- Expression of ITGB5 remains unchanged in aggregate culture.
63
 
- Expression of ITGAV Day 20/Day 0 was 5.2 in pellet culture.
75
 
ITGB8 
Very important 
upregulation 
Relatively stable αVβ8  Very important variations in expression levels were observed 
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6. Conclusion and Prospect 
In the present work, we investigated integrin subunit transcript expression during hMSC 
chondrogenesis in pellet culture, micromass culture and collagen type II hydrogels. We were able to 
establish an expression profile over time for each integrin subunit according to the culture system. 
The chondrocyte phenotype markers expression analysis along with the histology staining revealed 
that the system where the most ECM was produced was pellet culture. However the data suggests 
that fibrocartilage is produced and that chondrocytes in pellet culture might eventually undergo 
hypertrophy as a final stage of differentiation. On the other hand, hMSCs undergoing chondrogenesis 
in collagen type II gels revealed the best phenotype, yet one should stimulate the production of ECM 
in order to make this culture system superior to the two other systems investigated.  
We demonstrated that integrins are overall more expressed in hMSCs cultured in growth conditions 
than in hMSCs undergoing chondrogenic differentiation. Nonetheless integrin subunits α11 and αV 
were more expressed in chondrogenic conditions and might thus play an important role to direct 
stem cell differentiation toward chondrocytes. Furthermore, we identified identical expression 
profiles over time for the alpha subunits related to collagen-binding integrins irrespective to the 
culture systems, while the profile of fibronectin- and laminin-binding receptors was variable and 
seemed dependent on the culture method. 
This project was the first step of a larger study which seeks to elucidate the role of integrins during 
chondrogenic differentiation. Thus the initial step was to establish integrin subunits transcript 
expression in order to carry out further investigations. The next step is to link the observed integrin 
expression in this study to the role of integrins in driving chondrogenesis. For instance, disregulation 
of integrin signalling with antibodies could prove that the integrin subunits we quantified are 
important regulators of chondrogenesis. More interestingly, the huge data collected during this 
project can be interpreted in order to present the right ligand over time to promote differentiation 
and stabilise chondrocyte phenotype. One could imagine to seed hMSCs in 3D hydrogel where an 
integrin receptor ligand for hMSCs would be presented and over time, the desired ligands for 
chondrocytes would become available. 
In conclusion, this work has led to an improved understanding of the expression of integrins in 
hMSCs and during chondrogenesis and this knowledge can be used to design biomaterial that mimics 
endogenous integrin binding pattern as reproducing integrin temporal expression could significantly 
improve chondrogenic differentiation in tissue engineered constructs. 
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7. Appendix 
7.1. qPCR for Primer Validation 
7.1.1. ITGA1 v2 
Efficiency R
2
 Threshold 
0.98 0.94021 0.1496 
  
 
 
 
 
 
 
 
 
 
 
7.1.2. ITGA2 v1 
Efficiency R
2
 Threshold 
0.93 0.99659 0.1958 
 
 
 
 
 
 
 
 
 
 
Figure 29 - Primer validation for ITGA1. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
B 
D C 
A 
B 
D C 
A 
Figure 30 - Primer validation for ITGA2. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
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7.1.3. ITGA3 v3 
Efficiency R
2
 Threshold 
1.00 0.98731 0.1498 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.1.4. ITGA4 QIAGEN 
Efficiency R
2
 Threshold 
1.01 0.9896 0.1321 
 
 
 
 
 
 
 
 
 
 
 
B 
D C 
A 
Figure 31 - Primer validation for ITGA3. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
 
Figure 32 - Primer validation for ITGA4. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
 
B 
D C 
A 
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7.1.5. ITGA5 v1 
Efficiency R
2
 Threshold 
1.00 0.99695 0.0838 
 
 
 
 
 
 
 
 
 
 
Figure 33 - Primer validation for ITGA5. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
 
7.1.6. ITGA6 QIAGEN 
Efficiency R
2
 Threshold 
0.9 0.9694 0.145 
 
 
 
 
 
 
 
 
 
 
Figure 34 - Primer validation for ITGA6. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
B 
D C 
A 
B 
D C 
A 
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7.1.7. ITGA7 v2 
Efficiency R
2
 Threshold 
0.98 0.97420 0.03 
 
 
 
 
 
 
 
 
 
 
Figure 35 - Primer validation for ITGA7. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
 
7.1.8. ITGA10 v1 
Efficiency R
2
 Threshold 
1.00 0.9968 0.1340 
 
 
 
 
 
 
 
 
 
 
 
Figure 36 - Primer validation for ITGA10. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
B 
D C 
A 
B 
D C 
A 
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7.1.9. ITGA11 v1 
Efficiency R
2
 Threshold 
1.09 0.97012 0.03 
 
 
 
 
 
 
 
 
 
 
 
Figure 37 - Primer validation for ITGA11. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
7.1.10. ITGAV v1 
Efficiency R
2
 Threshold 
0.96 0.9921 0.0712 
 
 
 
 
 
 
 
 
 
 
Figure 38 - Primer validation for ITGAV. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
B 
D C 
A 
B 
D C 
A 
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7.1.11. ITGB1 v2 
Efficiency R
2
 Threshold 
0.96 0.9991 0.1229 
 
 
 
 
 
 
 
 
 
 
 
Figure 39 - Primer validation for ITGB1. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
7.1.12. ITGB3 v1 
Efficiency R
2
 Threshold 
0.99 0.9963 0.02 
 
 
 
 
 
 
 
 
 
 
Figure 40 - Primer validation for ITGB3. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
B 
D C 
A 
B 
D C 
A 
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7.1.13. ITGB5 v2 
Efficiency R
2
 Threshold 
0.98 0.9676 0.1498 
 
 
 
 
 
 
 
 
 
 
Figure 41 - Primer validation for ITGB5. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
7.1.14. ITGB8 v2 
Efficiency R
2
 Threshold 
0.99 0.9709 0.1268 
 
 
 
 
 
 
 
 
 
 
 
Figure 42 - Primer validation for ITGB8. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
B 
D C 
A 
B 
D C 
A 
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7.1.15. ACAN 
Efficiency R
2
 Threshold 
0.91 0.9895 0.04 
 
 
 
 
 
 
 
 
 
 
Figure 43 - Primer validation for ACAN. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
7.1.16. COL1A1 
Efficiency R
2
 Threshold 
0.93 0.9987 0.1472 
 
 
 
 
 
 
 
 
 
 
 
Figure 44 - Primer validation for COL1A1. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
B 
D C 
A 
B 
D C 
A 
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7.1.17. COL2A1 
Efficiency R
2
 Threshold 
1.00 0.9973 0.137 
 
 
 
 
 
 
 
 
 
 
Figure 45 - Primer validation for COL2A1. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
7.1.18. COL10A1 
Efficiency R
2
 Threshold 
1.01 0.9661 0.0344 
 
 
 
 
 
 
 
 
 
 
Figure 46 - Primer validation for COL10A1. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
B 
D C 
A 
B 
D C 
A 
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7.1.19. GAPDH 
Efficiency R
2
 Threshold 
0.97 0.9926 0.1498 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 47 - Primer validation for GAPDH. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
7.1.20. RUNX2 
Efficiency R
2
 Threshold 
1.05 0.99293 0.1498 
 
 
 
 
 
 
 
 
 
 
Figure 48 - Primer validation for RUNX2. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
B 
D C 
A 
B 
D C 
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7.1.21. SOX9 
Efficiency R
2
 Threshold 
0.9 0.9936 0.059 
 
 
 
 
 
 
 
 
 
 
Figure 49 - Primer validation for SOX9. In order to get a standard curve, the qPCR was performed in technical triplicates 
with a serial dilution ofcDNA from hMSCs cultured on tissue culture plastic, dilutions were 1:10, 1:50, 1:100, 1:1000 and 
1:10000. Amplification curves (A), quantification curves and threshold (B), melt curve (C), and standard curve (D). 
 
 
7.2. Gel Electrophoresis UV Pictures  
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